NUMINOUS adj. /ˈnuːmɪnəs/ A term derived from the Latin numen, meaning "arousing spiritual emotion; mysterious or awe-inspiring."
Numinous Ways Psychedelic Library
We’re building a complete list of books and articles about psychedelics. This includes everything we’ve mentioned in our articles and additional items suggested by our readers.
You can get each item in RIS format for your reference software by clicking the ‘CITE’ link. We like using Zotero. If you know of a title we should add, please let us know through this form. Remember to use APA format and include the DOI identifier when you suggest a title
Bibliography
<aside id="wp-widget-zotpresssidebarwidget" class="widget wp-widget-zotpresssidebarwidget">
</aside>
1176526 CNBFREKQ 1 apa 50 default desc 12155 https://numinousways.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A800%2C%22request_next%22%3A50%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22BS6WPESK%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Aaronson%20et%20al.%22%2C%22parsedDate%22%3A%222023-12-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAaronson%2C%20S.%20T.%2C%20van%20der%20Vaart%2C%20A.%2C%20Miller%2C%20T.%2C%20LaPratt%2C%20J.%2C%20Swartz%2C%20K.%2C%20Shoultz%2C%20A.%2C%20Lauterbach%2C%20M.%2C%20Sackeim%2C%20H.%20A.%2C%20%26amp%3B%20Suppes%2C%20T.%20%282023%29.%20Single-Dose%20Synthetic%20Psilocybin%20With%20Psychotherapy%20for%20Treatment-Resistant%20Bipolar%20Type%20II%20Major%20Depressive%20Episodes%3A%20A%20Nonrandomized%20Controlled%20Trial.%20%26lt%3Bi%26gt%3BJAMA%20Psychiatry%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1001%5C%2Fjamapsychiatry.2023.4685%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1001%5C%2Fjamapsychiatry.2023.4685%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Single-Dose%20Synthetic%20Psilocybin%20With%20Psychotherapy%20for%20Treatment-Resistant%20Bipolar%20Type%20II%20Major%20Depressive%20Episodes%3A%20A%20Nonrandomized%20Controlled%20Trial%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20T.%22%2C%22lastName%22%3A%22Aaronson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22van%20der%20Vaart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tammy%22%2C%22lastName%22%3A%22Miller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%22%2C%22lastName%22%3A%22LaPratt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kimberly%22%2C%22lastName%22%3A%22Swartz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Audrey%22%2C%22lastName%22%3A%22Shoultz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Margo%22%2C%22lastName%22%3A%22Lauterbach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harold%20A.%22%2C%22lastName%22%3A%22Sackeim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Trisha%22%2C%22lastName%22%3A%22Suppes%22%7D%5D%2C%22abstractNote%22%3A%22Bipolar%20II%20disorder%20%28BDII%29%20is%20a%20debilitating%20condition%20frequently%20associated%20with%20difficult-to-treat%20depressive%20episodes.%20Psilocybin%20has%20evidence%20for%20rapid-acting%20antidepressant%20effects%20but%20has%20not%20been%20investigated%20in%20bipolar%20depression.To%20establish%20the%20safety%20and%20efficacy%20of%20psilocybin%20in%20patients%20with%20BDII%20in%20a%20current%20depressive%20episode.This%20was%20a%2012-week%2C%20open-label%20nonrandomized%20controlled%20trial%20conducted%20at%20Sheppard%20Pratt%20Hospital.%20Participants%20aged%2018%20to%2065%20years%20with%20BDII%2C%20a%20current%20depressive%20episode%20longer%20than%203%20months%2C%20and%20documented%20insufficient%20benefit%20with%20at%20least%202%20pharmacologic%20treatments%20during%20the%20current%20episode%20were%20invited%20to%20participate.%20Of%2070%20approached%2C%2019%20met%20inclusion%20criteria%20and%20were%20enrolled.%20The%20trial%20was%20conducted%20between%20April%2014%2C%202021%2C%20and%20January%205%2C%202023.A%20single%20dose%20of%20synthetic%20psilocybin%2C%2025%20mg%2C%20was%20administered.%20Psychotropic%20medications%20were%20discontinued%20at%20least%202%20weeks%20prior%20to%20dosing.%20Therapists%20met%20with%20patients%20for%203%20sessions%20during%20pretreatment%2C%20during%20the%208-hour%20dosing%20day%2C%20and%20for%203%20integration%20sessions%20posttreatment.The%20primary%20outcome%20measure%20was%20change%20in%20Montgomery-%5Cu00c5sberg%20Depression%20Rating%20scale%20%28MADRS%29%20at%203%20weeks%20posttreatment.%20Secondary%20measures%20included%20MADRS%20scores%2012%20weeks%20posttreatment%2C%20the%20self-rated%20Quick%20Inventory%20of%20Depression%20Symptoms-Self%20Rating%20%28QIDS-SR%29%2C%20and%20the%20self-rated%20Quality%20of%20Life%20Enjoyment%20and%20Satisfaction%20Questionnaire-Short%20Form%20%28Q-LES-Q-SF%29%2C%20each%20completed%20at%20baseline%20and%20all%20subsequent%20visits.%20Safety%20measures%20included%20the%20Columbia%20Suicide%20Severity%20Rating%20Scale%20%28CSSRS%29%20and%20the%20Young%20Mania%20Rating%20Scale%20%28YMRS%29%20completed%20at%20each%20visit.Of%20the%2015%20participants%20in%20this%20study%20%286%20male%20and%209%20female%3B%20mean%20%5BSD%5D%20age%2C%2037.8%20%5B11.6%5D%20years%29%2C%20all%20had%20lower%20scores%20at%20week%203%2C%20with%20a%20mean%20%28SD%29%20change%20of%20%5Cu221224.00%20%289.23%29%20points%20on%20the%20MADRS%2C%20%28Cohen%20d%5Cu2009%3D%5Cu20094.08%3B%2095%25%20CI%2C%20%5Cu221229.11%20to%20%5Cu221218.89%3B%20P%5Cu2009%26lt%3B%5Cu2009.001%29.%20Repeat%20measures%20analysis%20of%20variance%20showed%20lower%20MADRS%20scores%20at%20all%20tested%20posttreatment%20time%20points%2C%20including%20the%20end%20point%20%28Cohen%20d%5Cu2009%3D%5Cu20093.39%3B%2095%25%20CI%2C%20%5Cu221233.19%20to%20%5Cu221216.95%3B%20adjusted%20P%5Cu2009%26lt%3B%5Cu2009.001%29.%20At%20week%203%2C%2012%20participants%20met%20the%20response%20criterion%20%2850%25%20decrease%20in%20MADRS%29%2C%20and%2011%20met%20remission%20criterion%20%28MADRS%20score%20%5Cu226410%29.%20At%20the%20study%20end%20point%2C%2012%20patients%20met%20both%20response%20and%20remission%20criteria.%20QIDS-SR%20scores%20and%20Q-LES-Q-SF%20scores%20demonstrated%20similar%20improvements.%20YMRS%20and%20CSSRS%20scores%20did%20not%20change%20significantly%20at%20posttreatment%20compared%20to%20baseline.The%20findings%20in%20this%20open-label%20nonrandomized%20controlled%20trial%20suggest%20efficacy%20and%20safety%20of%20psilocybin%20with%20psychotherapy%20in%20BDII%20depression%20and%20supports%20further%20study%20of%20psychedelics%20in%20this%20population.%22%2C%22date%22%3A%222023-12-06%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1001%5C%2Fjamapsychiatry.2023.4685%22%2C%22ISSN%22%3A%222168-622X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1001%5C%2Fjamapsychiatry.2023.4685%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22ETKRA2XC%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Barrett%20et%20al.%22%2C%22parsedDate%22%3A%222018-07-04%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBarrett%2C%20F.%20S.%2C%20Preller%2C%20K.%20H.%2C%20%26amp%3B%20Kaelen%2C%20M.%20%282018%29.%20Psychedelics%20and%20music%3A%20neuroscience%20and%20therapeutic%20implications.%20%26lt%3Bi%26gt%3BInternational%20Review%20of%20Psychiatry%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B30%26lt%3B%5C%2Fi%26gt%3B%284%29%2C%20350%26%23x2013%3B362.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F09540261.2018.1484342%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F09540261.2018.1484342%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Psychedelics%20and%20music%3A%20neuroscience%20and%20therapeutic%20implications%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frederick%20S.%22%2C%22lastName%22%3A%22Barrett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katrin%20H.%22%2C%22lastName%22%3A%22Preller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mendel%22%2C%22lastName%22%3A%22Kaelen%22%7D%5D%2C%22abstractNote%22%3A%22From%20the%20beginning%20of%20therapeutic%20research%20with%20psychedelics%2C%20music%20listening%20has%20been%20consistently%20used%20as%20a%20method%20to%20guide%20or%20support%20therapeutic%20experiences%20during%20the%20acute%20effects%20of%20psychedelic%20drugs.%20Recent%20findings%20point%20to%20the%20potential%20of%20music%20to%20support%20meaning-making%2C%20emotionality%2C%20and%20mental%20imagery%20after%20the%20administration%20of%20psychedelics%2C%20and%20suggest%20that%20music%20plays%20an%20important%20role%20in%20facilitating%20positive%20clinical%20outcomes%20of%20psychedelic%20therapy.%20This%20review%20explores%20the%20history%20of%2C%20contemporary%20research%20on%2C%20and%20future%20directions%20regarding%20the%20use%20of%20music%20in%20psychedelic%20research%20and%20therapy%2C%20and%20argues%20for%20more%20detailed%20and%20rigorous%20investigation%20of%20the%20contribution%20of%20music%20to%20the%20treatment%20of%20psychiatric%20disorders%20within%20the%20novel%20framework%20of%20psychedelic%20therapy.%22%2C%22date%22%3A%222018-07-04%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1080%5C%2F09540261.2018.1484342%22%2C%22ISSN%22%3A%220954-0261%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F09540261.2018.1484342%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22L5IWGH4G%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Luan%20et%20al.%22%2C%22parsedDate%22%3A%222023-10-28%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLuan%2C%20L.%20X.%2C%20Eckern%26%23xE4%3Bs%2C%20E.%2C%20Ashton%2C%20M.%2C%20Rosas%2C%20F.%20E.%2C%20Uthaug%2C%20M.%20V.%2C%20Bartha%2C%20A.%2C%20Jagger%2C%20S.%2C%20Gascon-Perai%2C%20K.%2C%20Gomes%2C%20L.%2C%20Nutt%2C%20D.%20J.%2C%20Erritz%26%23xF8%3Be%2C%20D.%2C%20Carhart-Harris%2C%20R.%20L.%2C%20%26amp%3B%20Timmermann%2C%20C.%20%282023%29.%20Psychological%20and%20physiological%20effects%20of%20extended%20DMT.%20%26lt%3Bi%26gt%3BJournal%20of%20Psychopharmacology%26lt%3B%5C%2Fi%26gt%3B%2C%2002698811231196877.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1177%5C%2F02698811231196877%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1177%5C%2F02698811231196877%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Psychological%20and%20physiological%20effects%20of%20extended%20DMT%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%20X%22%2C%22lastName%22%3A%22Luan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emma%22%2C%22lastName%22%3A%22Eckern%5Cu00e4s%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Ashton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%20E%22%2C%22lastName%22%3A%22Rosas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Malin%20V%22%2C%22lastName%22%3A%22Uthaug%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Bartha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samantha%22%2C%22lastName%22%3A%22Jagger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kiara%22%2C%22lastName%22%3A%22Gascon-Perai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lauren%22%2C%22lastName%22%3A%22Gomes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20J%22%2C%22lastName%22%3A%22Nutt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Erritz%5Cu00f8e%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robin%20L%22%2C%22lastName%22%3A%22Carhart-Harris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Timmermann%22%7D%5D%2C%22abstractNote%22%3A%22N%2CN-Dimethyltryptamine%20%28DMT%29%20is%20a%20serotonergic%20psychedelic%20that%20induces%20a%20rapid%20and%20transient%20altered%20state%20of%20consciousness%20when%20inhaled%20or%20injected%20via%20bolus%20administration.%20Its%20marked%20and%20novel%20subjective%20effects%20make%20DMT%20a%20powerful%20tool%20for%20the%20neuroscientific%20study%20of%20consciousness%20and%20preliminary%20results%20show%20its%20potential%20role%20in%20treating%20mental%20health%20conditions.%20In%20a%20within-subjects%2C%20placebo-controlled%20study%2C%20we%20investigated%20a%20novel%20method%20of%20DMT%20administration%20involving%20a%20bolus%20injection%20paired%20with%20a%20constant-rate%20infusion%2C%20with%20the%20goal%20of%20extending%20the%20DMT%20experience.%20Pharmacokinetic%20parameters%20of%20DMT%20estimated%20from%20plasma%20data%20of%20a%20previous%20study%20of%20bolus%20intravenous%20DMT%20were%20used%20to%20derive%20dose%20regimens%20necessary%20to%20keep%20subjects%20in%20steady%20levels%20of%20immersion%20into%20the%20DMT%20experience%20over%20an%20extended%20period%20of%2030%5Cu2009min%2C%20and%20four%20dose%20regimens%20consisting%20of%20a%20bolus%20loading%20dose%20and%20a%20slow-rate%20infusion%20were%20tested%20in%20eleven%20healthy%20volunteers%20%28seven%20male%2C%20four%20female%2C%20mean%20age%5Cu2009%5Cu00b1%5Cu2009SD%5Cu2009%3D%5Cu200937.09%5Cu2009%5Cu00b1%5Cu20098.93%5Cu2009years%29.%20The%20present%20method%20is%20effective%20for%20extending%20the%20DMT%20experience%20in%20a%20stable%20and%20tolerable%20fashion.%20While%20subjective%20effects%20were%20maintained%20over%20the%20period%20of%20active%20infusion%2C%20anxiety%20ratings%20remained%20low%20and%20heart%20rate%20habituated%20within%2015%5Cu2009min%2C%20indicating%20psychological%20and%20physiological%20safety%20of%20extended%20DMT.%20Plasma%20DMT%20concentrations%20increased%20consistently%20starting%2010%5Cu2009min%20into%20DMT%20administration%2C%20whereas%20psychological%20effects%20plateaued%20into%20the%20desired%20steady%20state%2C%20suggesting%20the%20development%20of%20acute%20psychological%20tolerance%20to%20DMT.%20Taken%20together%2C%20these%20findings%20demonstrate%20the%20safety%20and%20effectiveness%20of%20continuous%20IV%20DMT%20administration%2C%20laying%20the%20groundwork%20for%20the%20further%20development%20of%20this%20method%20of%20administration%20for%20basic%20and%20clinical%20research.%22%2C%22date%22%3A%222023-10-28%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1177%5C%2F02698811231196877%22%2C%22ISSN%22%3A%220269-8811%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1177%5C%2F02698811231196877%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22V95C2J83%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gr%5Cu00fcnder%20et%20al.%22%2C%22parsedDate%22%3A%222023-12-12%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGr%26%23xFC%3Bnder%2C%20G.%2C%20Brand%2C%20M.%2C%20Mertens%2C%20L.%20J.%2C%20Jungaberle%2C%20H.%2C%20K%26%23xE4%3Brtner%2C%20L.%2C%20Scharf%2C%20D.%20J.%2C%20Spangemacher%2C%20M.%2C%20%26amp%3B%20Wolff%2C%20M.%20%282023%29.%20Treatment%20with%20psychedelics%20is%20psychotherapy%3A%20beyond%20reductionism.%20%26lt%3Bi%26gt%3BThe%20Lancet%20Psychiatry%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B0%26lt%3B%5C%2Fi%26gt%3B%280%29.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2215-0366%2823%2900363-2%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2215-0366%2823%2900363-2%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Treatment%20with%20psychedelics%20is%20psychotherapy%3A%20beyond%20reductionism%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gerhard%22%2C%22lastName%22%3A%22Gr%5Cu00fcnder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manuela%22%2C%22lastName%22%3A%22Brand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lea%20J.%22%2C%22lastName%22%3A%22Mertens%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Henrik%22%2C%22lastName%22%3A%22Jungaberle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22K%5Cu00e4rtner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dennis%20J.%22%2C%22lastName%22%3A%22Scharf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moritz%22%2C%22lastName%22%3A%22Spangemacher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Max%22%2C%22lastName%22%3A%22Wolff%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222023-12-12%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1016%5C%2FS2215-0366%2823%2900363-2%22%2C%22ISSN%22%3A%222215-0366%2C%202215-0374%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.thelancet.com%5C%2Fjournals%5C%2Flanpsy%5C%2Farticle%5C%2FPIIS2215-0366%2823%2900363-2%5C%2Ffulltext%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22XTH7Y82Z%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bi%26gt%3BThe%20Transpersonal%3A%20Spirituality%20in%20Psychotherapy%20and%20Counselling%26lt%3B%5C%2Fi%26gt%3B.%20%28n.d.%29.%20Routledge%20%26amp%3B%20CRC%20Press.%20Retrieved%20November%2013%2C%202023%2C%20from%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.routledge.com%5C%2FThe-Transpersonal-Spirituality-in-Psychotherapy-and-Counselling%5C%2FRowan%5C%2Fp%5C%2Fbook%5C%2F9781138881495%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fwww.routledge.com%5C%2FThe-Transpersonal-Spirituality-in-Psychotherapy-and-Counselling%5C%2FRowan%5C%2Fp%5C%2Fbook%5C%2F9781138881495%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22webpage%22%2C%22title%22%3A%22The%20Transpersonal%3A%20Spirituality%20in%20Psychotherapy%20and%20Counselling%22%2C%22creators%22%3A%5B%5D%2C%22abstractNote%22%3A%22In%20this%20new%20edition%20of%20The%20Transpersonal%2C%20John%20Rowan%20takes%20account%20of%20the%20growing%20interest%20in%20spirituality%2C%20assessing%20the%20many%20new%20developments%20in%20the%20field%20and%20providing%20an%20essential%20overview%20of%20the%20multitude%20of%20guides%20now%20available%20on%20the%20subject.%5CnBy%20providing%20a%20clear%20and%20highly%20readable%20introduction%20to%20the%20realm%20of%20the%20transpersonal%2C%20this%20book%20eliminates%20many%20of%20the%20misunderstandings%20that%20plague%20this%20area.%20It%20relates%20the%20transpersonal%20to%20everyday%20life%20as%20well%20as%20to%20professional%20concerns%20and%20t%22%2C%22date%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.routledge.com%5C%2FThe-Transpersonal-Spirituality-in-Psychotherapy-and-Counselling%5C%2FRowan%5C%2Fp%5C%2Fbook%5C%2F9781138881495%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22A3UCYZHK%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bi%26gt%3BThe%20Cosmic%20Game%3A%20Explorations%20of...%20by%20Grof%2C%20Stanislav%26lt%3B%5C%2Fi%26gt%3B.%20%28n.d.%29.%20Retrieved%20November%2013%2C%202023%2C%20from%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.amazon.co.uk%5C%2FCosmic-Game-Explorations-Consciousness-Transpersonal%5C%2Fdp%5C%2F0791438767%5C%2Fref%3Dsr_1_1%3Fcrid%3D10SSGELBX8O9Q%26amp%3Bkeywords%3Dgrof%2Bcosmic%26amp%3Bqid%3D1699840212%26amp%3Bs%3Dbooks%26amp%3Bsprefix%3Dgrof%2Bcosmic%252Cstripbooks%252C80%26amp%3Bsr%3D1-1%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fwww.amazon.co.uk%5C%2FCosmic-Game-Explorations-Consciousness-Transpersonal%5C%2Fdp%5C%2F0791438767%5C%2Fref%3Dsr_1_1%3Fcrid%3D10SSGELBX8O9Q%26amp%3Bkeywords%3Dgrof%2Bcosmic%26amp%3Bqid%3D1699840212%26amp%3Bs%3Dbooks%26amp%3Bsprefix%3Dgrof%2Bcosmic%252Cstripbooks%252C80%26amp%3Bsr%3D1-1%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22webpage%22%2C%22title%22%3A%22The%20Cosmic%20Game%3A%20Explorations%20of...%20by%20Grof%2C%20Stanislav%22%2C%22creators%22%3A%5B%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.amazon.co.uk%5C%2FCosmic-Game-Explorations-Consciousness-Transpersonal%5C%2Fdp%5C%2F0791438767%5C%2Fref%3Dsr_1_1%3Fcrid%3D10SSGELBX8O9Q%26keywords%3Dgrof%2Bcosmic%26qid%3D1699840212%26s%3Dbooks%26sprefix%3Dgrof%2Bcosmic%252Cstripbooks%252C80%26sr%3D1-1%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22Y3GXVAQX%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Letheby%22%2C%22parsedDate%22%3A%222021%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLetheby%2C%20C.%20%282021%29.%20%26lt%3Bi%26gt%3BPhilosophy%20of%20Psychedelics%26lt%3B%5C%2Fi%26gt%3B.%20Oxford%20University%20Press.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fphilarchive.org%5C%2Frec%5C%2FLETPOP%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fphilarchive.org%5C%2Frec%5C%2FLETPOP%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22book%22%2C%22title%22%3A%22Philosophy%20of%20Psychedelics%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chris%22%2C%22lastName%22%3A%22Letheby%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222021%22%2C%22language%22%3A%22%22%2C%22ISBN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fphilarchive.org%5C%2Frec%5C%2FLETPOP%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22F4UGMQ7X%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bi%26gt%3BThe%20Transpersonal%3A%20Spirituality...%20by%20Rowan%2C%20John%26lt%3B%5C%2Fi%26gt%3B.%20%28n.d.%29.%20Retrieved%20November%2013%2C%202023%2C%20from%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.amazon.co.uk%5C%2FTranspersonal-John-Rowan%5C%2Fdp%5C%2F1583919872%5C%2Fref%3Dsr_1_3%3Fcrid%3D17M4WK9OHWLWV%26amp%3Bkeywords%3Drowan%2Bjohn%26amp%3Bqid%3D1699840354%26amp%3Bs%3Dbooks%26amp%3Bsprefix%3Drowan%2Bjohn%252Cstripbooks%252C88%26amp%3Bsr%3D1-3%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fwww.amazon.co.uk%5C%2FTranspersonal-John-Rowan%5C%2Fdp%5C%2F1583919872%5C%2Fref%3Dsr_1_3%3Fcrid%3D17M4WK9OHWLWV%26amp%3Bkeywords%3Drowan%2Bjohn%26amp%3Bqid%3D1699840354%26amp%3Bs%3Dbooks%26amp%3Bsprefix%3Drowan%2Bjohn%252Cstripbooks%252C88%26amp%3Bsr%3D1-3%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22webpage%22%2C%22title%22%3A%22The%20Transpersonal%3A%20Spirituality...%20by%20Rowan%2C%20John%22%2C%22creators%22%3A%5B%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.amazon.co.uk%5C%2FTranspersonal-John-Rowan%5C%2Fdp%5C%2F1583919872%5C%2Fref%3Dsr_1_3%3Fcrid%3D17M4WK9OHWLWV%26keywords%3Drowan%2Bjohn%26qid%3D1699840354%26s%3Dbooks%26sprefix%3Drowan%2Bjohn%252Cstripbooks%252C88%26sr%3D1-3%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%226KRKUW4N%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bi%26gt%3BThe%20Transpersonal%3A%20Psychotherapy%20and...%20by%20Rowan%2C%20John%26lt%3B%5C%2Fi%26gt%3B.%20%28n.d.%29.%20Retrieved%20November%2013%2C%202023%2C%20from%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.amazon.co.uk%5C%2FTranspersonal-Psychotherapy-Counselling-John-Rowan%5C%2Fdp%5C%2F0415053625%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fwww.amazon.co.uk%5C%2FTranspersonal-Psychotherapy-Counselling-John-Rowan%5C%2Fdp%5C%2F0415053625%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22webpage%22%2C%22title%22%3A%22The%20Transpersonal%3A%20Psychotherapy%20and...%20by%20Rowan%2C%20John%22%2C%22creators%22%3A%5B%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.amazon.co.uk%5C%2FTranspersonal-Psychotherapy-Counselling-John-Rowan%5C%2Fdp%5C%2F0415053625%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22TMFX84QR%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bi%26gt%3BOtherworlds%3A%20Psychedelics%20and%20Exceptional%20Human%20Experience%20%28Muswell%20Hill%20Press%29%26%23x202F%3B%3A%20Luke%2C%20David%3A%20Amazon.co.uk%3A%20Books%26lt%3B%5C%2Fi%26gt%3B.%20%28n.d.%29.%20Retrieved%20November%2013%2C%202023%2C%20from%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.amazon.co.uk%5C%2FOtherworlds-Psychedelics-Exceptional-Experience-Muswell%5C%2Fdp%5C%2F1908995149%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fwww.amazon.co.uk%5C%2FOtherworlds-Psychedelics-Exceptional-Experience-Muswell%5C%2Fdp%5C%2F1908995149%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22webpage%22%2C%22title%22%3A%22Otherworlds%3A%20Psychedelics%20and%20Exceptional%20Human%20Experience%20%28Muswell%20Hill%20Press%29%20%3A%20Luke%2C%20David%3A%20Amazon.co.uk%3A%20Books%22%2C%22creators%22%3A%5B%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.amazon.co.uk%5C%2FOtherworlds-Psychedelics-Exceptional-Experience-Muswell%5C%2Fdp%5C%2F1908995149%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22NZYBRMLA%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hoffman%22%2C%22parsedDate%22%3A%222020-08-20%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHoffman%2C%20D.%20D.%20%282020%29.%20%26lt%3Bi%26gt%3BThe%20Case%20Against%20Reality%3A%20How%20Evolution%20Hid%20the%20Truth%20from%20Our%20Eyes%26lt%3B%5C%2Fi%26gt%3B%20%281st%20edition%29.%20Penguin.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22book%22%2C%22title%22%3A%22The%20Case%20Against%20Reality%3A%20How%20Evolution%20Hid%20the%20Truth%20from%20Our%20Eyes%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Donald%20D.%22%2C%22lastName%22%3A%22Hoffman%22%7D%5D%2C%22abstractNote%22%3A%22SHORTLISTED%20FOR%20THE%20PHYSICS%20WORLD%20BOOK%20OF%20THE%20YEAR%202019%26%23039%3BOne%20of%20the%20deepest%20and%20most%20original%20thinkers%20of%20his%20generation%20of%20cognitive%20scientists.%20His%20startling%20argument%20has%20implications%20for%20philosophy%2C%20science%2C%20and%20how%20we%20understand%20the%20world%20around%20us%26%23039%3B%20Steven%20Pinker%20%26%23039%3BIs%20reality%20virtual%3F%20It%26%23039%3Bs%20a%20question%20made%20even%20more%20interesting%20by%20this%20book%26%23039%3B%20Barbara%20Kiser%2C%20Nature%20Do%20we%20see%20the%20world%20as%20it%20truly%20is%3F%20In%20The%20Case%20Against%20Reality%2C%20pioneering%20cognitive%20scientist%20Donald%20Hoffman%20says%20no%3F%20we%20see%20what%20we%20need%20in%20order%20to%20survive.%20Our%20visual%20perceptions%20are%20not%20a%20window%20onto%20reality%2C%20Hoffman%20shows%20us%2C%20but%20instead%20are%20interfaces%20constructed%20by%20natural%20selection.%20The%20objects%20we%20see%20around%20us%20are%20not%20unlike%20the%20file%20icons%20on%20our%20computer%20desktops%3A%20while%20shaped%20like%20a%20small%20folder%20on%20our%20screens%2C%20the%20files%20themselves%20are%20made%20of%20a%20series%20of%20ones%20and%20zeros%20-%20too%20complex%20for%20most%20of%20us%20to%20understand.%20In%20a%20similar%20way%2C%20Hoffman%20argues%2C%20evolution%20has%20shaped%20our%20perceptions%20into%20simplistic%20illusions%20to%20help%20us%20navigate%20the%20world%20around%20us.%20Yet%20now%20these%20illusions%20can%20be%20manipulated%20by%20advertising%20and%20design.Drawing%20on%20thirty%20years%20of%20Hoffman%26%23039%3Bs%20own%20influential%20research%2C%20as%20well%20as%20evolutionary%20biology%2C%20game%20theory%2C%20neuroscience%2C%20and%20philosophy%2C%20The%20Case%20Against%20Reality%20makes%20the%20mind-bending%20yet%20utterly%20convincing%20case%20that%20the%20world%20is%20nothing%20like%20what%20we%20see%20through%20our%20eyes.%22%2C%22date%22%3A%222020-08-20%22%2C%22language%22%3A%22English%22%2C%22ISBN%22%3A%22978-0-14-198341-7%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%226QU2SYAB%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Carhart-Harris%20and%20Goodwin%22%2C%22parsedDate%22%3A%222017-10%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCarhart-Harris%2C%20R.%20L.%2C%20%26amp%3B%20Goodwin%2C%20G.%20M.%20%282017%29.%20The%20Therapeutic%20Potential%20of%20Psychedelic%20Drugs%3A%20Past%2C%20Present%2C%20and%20Future.%20%26lt%3Bi%26gt%3BNeuropsychopharmacology%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B42%26lt%3B%5C%2Fi%26gt%3B%2811%29%2C%202105%26%23x2013%3B2113.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fnpp.2017.84%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fnpp.2017.84%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20Therapeutic%20Potential%20of%20Psychedelic%20Drugs%3A%20Past%2C%20Present%2C%20and%20Future%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robin%20L%22%2C%22lastName%22%3A%22Carhart-Harris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guy%20M%22%2C%22lastName%22%3A%22Goodwin%22%7D%5D%2C%22abstractNote%22%3A%22Plant-based%20psychedelics%2C%20such%20as%20psilocybin%2C%20have%20an%20ancient%20history%20of%20medicinal%20use.%20After%20the%20first%20English%20language%20report%20on%20LSD%20in%201950%2C%20psychedelics%20enjoyed%20a%20short-lived%20relationship%20with%20psychology%20and%20psychiatry.%20Used%20most%20notably%20as%20aids%20to%20psychotherapy%20for%20the%20treatment%20of%20mood%20disorders%20and%20alcohol%20dependence%2C%20drugs%20such%20as%20LSD%20showed%20initial%20therapeutic%20promise%20before%20prohibitive%20legislature%20in%20the%20mid-1960s%20effectively%20ended%20all%20major%20psychedelic%20research%20programs.%20Since%20the%20early%201990s%2C%20there%20has%20been%20a%20steady%20revival%20of%20human%20psychedelic%20research%3A%20last%20year%20saw%20reports%20on%20the%20first%20modern%20brain%20imaging%20study%20with%20LSD%20and%20three%20separate%20clinical%20trials%20of%20psilocybin%20for%20depressive%20symptoms.%20In%20this%20circumspective%20piece%2C%20RLC-H%20and%20GMG%20share%20their%20opinions%20on%20the%20promises%20and%20pitfalls%20of%20renewed%20psychedelic%20research%2C%20with%20a%20focus%20on%20the%20development%20of%20psilocybin%20as%20a%20treatment%20for%20depression.%22%2C%22date%22%3A%222017-10%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1038%5C%2Fnpp.2017.84%22%2C%22ISSN%22%3A%220893-133X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5603818%5C%2F%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22HDSQJFD2%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Maclean%20et%20al.%22%2C%22parsedDate%22%3A%222012-12%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMaclean%2C%20K.%20A.%2C%20Leoutsakos%2C%20J.-M.%20S.%2C%20Johnson%2C%20M.%20W.%2C%20%26amp%3B%20Griffiths%2C%20R.%20R.%20%282012%29.%20Factor%20Analysis%20of%20the%20Mystical%20Experience%20Questionnaire%3A%20A%20Study%20of%20Experiences%20Occasioned%20by%20the%20Hallucinogen%20Psilocybin.%20%26lt%3Bi%26gt%3BJournal%20for%20the%20Scientific%20Study%20of%20Religion%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B51%26lt%3B%5C%2Fi%26gt%3B%284%29%2C%20721%26%23x2013%3B737.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fj.1468-5906.2012.01685.x%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fj.1468-5906.2012.01685.x%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Factor%20Analysis%20of%20the%20Mystical%20Experience%20Questionnaire%3A%20A%20Study%20of%20Experiences%20Occasioned%20by%20the%20Hallucinogen%20Psilocybin%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%20A.%22%2C%22lastName%22%3A%22Maclean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeannie-Marie%20S.%22%2C%22lastName%22%3A%22Leoutsakos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20W.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roland%20R.%22%2C%22lastName%22%3A%22Griffiths%22%7D%5D%2C%22abstractNote%22%3A%22A%20large%20body%20of%20historical%20evidence%20describes%20the%20use%20of%20hallucinogenic%20compounds%2C%20such%20as%20psilocybin%20mushrooms%2C%20for%20religious%20purposes.%20But%20few%20scientific%20studies%20have%20attempted%20to%20measure%20or%20characterize%20hallucinogen-occasioned%20spiritual%20experiences.%20The%20present%20study%20examined%20the%20factor%20structure%20of%20the%20Mystical%20Experience%20Questionnaire%20%28MEQ%29%2C%20a%20self-report%20measure%20that%20has%20been%20used%20to%20assess%20the%20effects%20of%20hallucinogens%20in%20laboratory%20studies.%20Participants%20%28N%3D1602%29%20completed%20the%2043-item%20MEQ%20in%20reference%20to%20a%20mystical%20or%20profound%20experience%20they%20had%20had%20after%20ingesting%20psilocybin.%20Exploratory%20factor%20analysis%20of%20the%20MEQ%20retained%2030%20items%20and%20revealed%20a%204-factor%20structure%20covering%20the%20dimensions%20of%20classic%20mystical%20experience%3A%20unity%2C%20noetic%20quality%2C%20sacredness%20%28F1%29%3B%20positive%20mood%20%28F2%29%3B%20transcendence%20of%20time%5C%2Fspace%20%28F3%29%3B%20and%20ineffability%20%28F4%29.%20MEQ%20factor%20scores%20showed%20good%20internal%20reliability%20and%20correlated%20with%20the%20Hood%20Mysticism%20Scale%2C%20indicating%20convergent%20validity.%20Participants%20who%20endorsed%20having%20had%20a%20mystical%20experience%20on%20psilocybin%2C%20compared%20to%20those%20who%20did%20not%2C%20had%20significantly%20higher%20factor%20scores%2C%20indicating%20construct%20validity.%20The%204-factor%20structure%20was%20confirmed%20in%20a%20second%20sample%20%28N%3D440%29%20and%20demonstrated%20superior%20fit%20compared%20to%20alternative%20models.%20The%20results%20provide%20initial%20evidence%20of%20the%20validity%2C%20reliability%2C%20and%20factor%20structure%20of%20a%2030-item%20scale%20for%20measuring%20single%2C%20hallucinogen-occasioned%20mystical%20experiences%2C%20which%20may%20be%20a%20useful%20tool%20in%20the%20scientific%20study%20of%20mysticism.%22%2C%22date%22%3A%222012-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Fj.1468-5906.2012.01685.x%22%2C%22ISSN%22%3A%220021-8294%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22G7NXCMVZ%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bi%26gt%3BSelf%20unbound%3A%20ego%20dissolution%20in%20psychedelic%20experience%20%7C%20Neuroscience%20of%20Consciousness%20%7C%20Oxford%20Academic%26lt%3B%5C%2Fi%26gt%3B.%20%28n.d.%29.%20Retrieved%20October%206%2C%202022%2C%20from%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Facademic.oup.com%5C%2Fnc%5C%2Farticle%5C%2F2017%5C%2F1%5C%2Fnix016%5C%2F3916730%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Facademic.oup.com%5C%2Fnc%5C%2Farticle%5C%2F2017%5C%2F1%5C%2Fnix016%5C%2F3916730%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22webpage%22%2C%22title%22%3A%22Self%20unbound%3A%20ego%20dissolution%20in%20psychedelic%20experience%20%7C%20Neuroscience%20of%20Consciousness%20%7C%20Oxford%20Academic%22%2C%22creators%22%3A%5B%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Facademic.oup.com%5C%2Fnc%5C%2Farticle%5C%2F2017%5C%2F1%5C%2Fnix016%5C%2F3916730%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22WZ5X53UP%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bi%26gt%3BSurvey%20of%20entity%20encounter%20experiences%20occasioned%20by%20inhaled%20N%2CN-dimethyltryptamine%3A%20Phenomenology%2C%20interpretation%2C%20and%20enduring%20effects%20-%20Alan%20K%20Davis%2C%20John%20M%20Clifton%2C%20Eric%20G%20Weaver%2C%20Ethan%20S%20Hurwitz%2C%20Matthew%20W%20Johnson%2C%20Roland%20R%20Griffiths%2C%202020%26lt%3B%5C%2Fi%26gt%3B.%20%28n.d.%29.%20Retrieved%20November%2011%2C%202023%2C%20from%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fjournals.sagepub.com%5C%2Fdoi%5C%2Ffull%5C%2F10.1177%5C%2F0269881120916143%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fjournals.sagepub.com%5C%2Fdoi%5C%2Ffull%5C%2F10.1177%5C%2F0269881120916143%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22webpage%22%2C%22title%22%3A%22Survey%20of%20entity%20encounter%20experiences%20occasioned%20by%20inhaled%20N%2CN-dimethyltryptamine%3A%20Phenomenology%2C%20interpretation%2C%20and%20enduring%20effects%20-%20Alan%20K%20Davis%2C%20John%20M%20Clifton%2C%20Eric%20G%20Weaver%2C%20Ethan%20S%20Hurwitz%2C%20Matthew%20W%20Johnson%2C%20Roland%20R%20Griffiths%2C%202020%22%2C%22creators%22%3A%5B%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fjournals.sagepub.com%5C%2Fdoi%5C%2Ffull%5C%2F10.1177%5C%2F0269881120916143%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22UBESCSEJ%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Huxley%22%2C%22parsedDate%22%3A%222004%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHuxley%2C%20A.%20%282004%29.%20%26lt%3Bi%26gt%3BThe%20doors%20of%20perception%20and%20Heaven%20and%20hell%26lt%3B%5C%2Fi%26gt%3B%20%281st%20Perennial%20Classics%20ed%29.%20Perennial%20Classics.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22book%22%2C%22title%22%3A%22The%20doors%20of%20perception%20and%20Heaven%20and%20hell%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aldous%22%2C%22lastName%22%3A%22Huxley%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222004%22%2C%22language%22%3A%22%22%2C%22ISBN%22%3A%22978-0-06-059518-0%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22H4IM8IE6%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Aday%20et%20al.%22%2C%22parsedDate%22%3A%222019-05-27%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAday%2C%20J.%20S.%2C%20Bloesch%2C%20E.%20K.%2C%20%26amp%3B%20Davoli%2C%20C.%20C.%20%282019%29.%20Beyond%20LSD%3A%20A%20Broader%20Psychedelic%20Zeitgeist%20during%20the%20Early%20to%20Mid-20th%20Century.%20%26lt%3Bi%26gt%3BJournal%20of%20Psychoactive%20Drugs%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B51%26lt%3B%5C%2Fi%26gt%3B%283%29%2C%20210%26%23x2013%3B217.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F02791072.2019.1581961%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F02791072.2019.1581961%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Beyond%20LSD%3A%20A%20Broader%20Psychedelic%20Zeitgeist%20during%20the%20Early%20to%20Mid-20th%20Century%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacob%20S.%22%2C%22lastName%22%3A%22Aday%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%20K.%22%2C%22lastName%22%3A%22Bloesch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20C.%22%2C%22lastName%22%3A%22Davoli%22%7D%5D%2C%22abstractNote%22%3A%22During%20the%201950s%20and%201960s%2C%20there%20was%20a%20tremendous%20surge%20in%20research%20into%20the%20effects%20of%20psychedelic%20drugs.%20When%20discussing%20this%20period%20of%20research%2C%20the%20discovery%20of%20the%20psychoactive%20properties%20of%20LSD%20in%201943%20is%20often%20presented%20as%20the%20main%2C%20and%20sometimes%20only%2C%20driving%20force%20of%20the%20boom%20in%20research.%20This%20%5Cu201cGreat%20Person%2C%5Cu201d%20or%20%5Cu201cGreat%20Chemical%2C%5Cu201d%20historiographical%20lens%20fails%20to%20acknowledge%20other%20factors%20that%20were%20fundamental%20in%20setting%20the%20stage%20for%20the%20research.%20In%20particular%2C%20other%20psychedelic%20drugs%2C%20such%20as%20mescaline%2C%20were%20already%20being%20probed%20for%20their%20uses%20in%20psychotherapy%20and%20as%20models%20for%20psychosis%20before%20the%20effects%20of%20LSD%20had%20been%20discovered.%20Psilocybin%20and%20other%20classical%20psychedelics%20had%20also%20been%20discovered%20by%20Western%20researchers%20around%20the%20same%20time%20as%20the%20synthesis%20of%20LSD.%20Additionally%2C%20many%20of%20the%20dominant%20zeitgeists%20%28e.g.%2C%20pharmacological%2C%20psychoanalytic%2C%20and%20humanistic%29%20in%20psychology%20during%20this%20period%20were%20congruent%20with%20psychedelic%20research.%20This%20article%20argues%20that%20while%20the%20discovery%20of%20LSD%20may%20have%20been%20a%20catalyst%20for%20psychedelic%20research%20in%20the%201950s%20and%20%5Cu201860s%2C%20there%20was%20a%20broader%20psychedelic%20zeitgeist%20that%20deserves%20acknowledgement%20for%20setting%20the%20stage.%22%2C%22date%22%3A%222019-05-27%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1080%5C%2F02791072.2019.1581961%22%2C%22ISSN%22%3A%220279-1072%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F02791072.2019.1581961%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22THWRYUF9%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Holze%20et%20al.%22%2C%22parsedDate%22%3A%222022-05%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHolze%2C%20F.%2C%20Ley%2C%20L.%2C%20M%26%23xFC%3Bller%2C%20F.%2C%20Becker%2C%20A.%20M.%2C%20Straumann%2C%20I.%2C%20Vizeli%2C%20P.%2C%20Kuehne%2C%20S.%20S.%2C%20Roder%2C%20M.%20A.%2C%20Duthaler%2C%20U.%2C%20Kolaczynska%2C%20K.%20E.%2C%20Varghese%2C%20N.%2C%20Eckert%2C%20A.%2C%20%26amp%3B%20Liechti%2C%20M.%20E.%20%282022%29.%20Direct%20comparison%20of%20the%20acute%20effects%20of%20lysergic%20acid%20diethylamide%20and%20psilocybin%20in%20a%20double-blind%20placebo-controlled%20study%20in%20healthy%20subjects.%20%26lt%3Bi%26gt%3BNeuropsychopharmacology%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B47%26lt%3B%5C%2Fi%26gt%3B%286%29%2C%201180%26%23x2013%3B1187.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41386-022-01297-2%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41386-022-01297-2%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Direct%20comparison%20of%20the%20acute%20effects%20of%20lysergic%20acid%20diethylamide%20and%20psilocybin%20in%20a%20double-blind%20placebo-controlled%20study%20in%20healthy%20subjects%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Friederike%22%2C%22lastName%22%3A%22Holze%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Ley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Felix%22%2C%22lastName%22%3A%22M%5Cu00fcller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20M.%22%2C%22lastName%22%3A%22Becker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabelle%22%2C%22lastName%22%3A%22Straumann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%22%2C%22lastName%22%3A%22Vizeli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sebastian%20Silva%22%2C%22lastName%22%3A%22Kuehne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%20A.%22%2C%22lastName%22%3A%22Roder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Urs%22%2C%22lastName%22%3A%22Duthaler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karolina%20E.%22%2C%22lastName%22%3A%22Kolaczynska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nimmy%22%2C%22lastName%22%3A%22Varghese%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Eckert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%20E.%22%2C%22lastName%22%3A%22Liechti%22%7D%5D%2C%22abstractNote%22%3A%22Growing%20interest%20has%20been%20seen%20in%20using%20lysergic%20acid%20diethylamide%20%28LSD%29%20and%20psilocybin%20in%20psychiatric%20research%20and%20therapy.%20However%2C%20no%20modern%20studies%20have%20evaluated%20differences%20in%20subjective%20and%20autonomic%20effects%20of%20LSD%20and%20psilocybin%20or%20their%20similarities%20and%20dose%20equivalence.%20We%20used%20a%20double-blind%2C%20randomized%2C%20placebo-controlled%2C%20crossover%20design%20in%2028%20healthy%20subjects%20%2814%20women%2C%2014%20men%29%20who%20underwent%20five%2025%5Cu2009h%20sessions%20and%20received%20placebo%2C%20LSD%20%28100%20and%20200%5Cu2009%5Cu00b5g%29%2C%20and%20psilocybin%20%2815%20and%2030%5Cu2009mg%29.%20Test%20days%20were%20separated%20by%20at%20least%2010%20days.%20Outcome%20measures%20included%20self-rating%20scales%20for%20subjective%20effects%2C%20autonomic%20effects%2C%20adverse%20effects%2C%20effect%20durations%2C%20plasma%20levels%20of%20brain-derived%20neurotrophic%20factor%20%28BDNF%29%2C%20prolactin%2C%20cortisol%2C%20and%20oxytocin%2C%20and%20pharmacokinetics.%20The%20doses%20of%20100%20and%20200%5Cu2009%5Cu00b5g%20LSD%20and%2030%5Cu2009mg%20psilocybin%20produced%20comparable%20subjective%20effects.%20The%2015%5Cu2009mg%20psilocybin%20dose%20produced%20clearly%20weaker%20subjective%20effects%20compared%20with%20both%20doses%20of%20LSD%20and%2030%5Cu2009mg%20psilocybin.%20The%20200%5Cu2009%5Cu00b5g%20dose%20of%20LSD%20induced%20higher%20ratings%20of%20ego-dissolution%2C%20impairments%20in%20control%20and%20cognition%2C%20and%20anxiety%20than%20the%20100%5Cu2009%5Cu00b5g%20dose.%20The%20200%5Cu2009%5Cu00b5g%20dose%20of%20LSD%20increased%20only%20ratings%20of%20ineffability%20significantly%20more%20than%2030%5Cu2009mg%20psilocybin.%20LSD%20at%20both%20doses%20had%20clearly%20longer%20effect%20durations%20than%20psilocybin.%20Psilocybin%20increased%20blood%20pressure%20more%20than%20LSD%2C%20whereas%20LSD%20increased%20heart%20rate%20more%20than%20psilocybin.%20However%2C%20both%20LSD%20and%20psilocybin%20showed%20comparable%20cardiostimulant%20properties%2C%20assessed%20by%20the%20rate-pressure%20product.%20Both%20LSD%20and%20psilocybin%20had%20dose-proportional%20pharmacokinetics%20and%20first-order%20elimination.%20Both%20doses%20of%20LSD%20and%20the%20high%20dose%20of%20psilocybin%20produced%20qualitatively%20and%20quantitatively%20very%20similar%20subjective%20effects%2C%20indicating%20that%20alterations%20of%20mind%20that%20are%20induced%20by%20LSD%20and%20psilocybin%20do%20not%20differ%20beyond%20the%20effect%20duration.%20Any%20differences%20between%20LSD%20and%20psilocybin%20are%20dose-dependent%20rather%20than%20substance-dependent.%20However%2C%20LSD%20and%20psilocybin%20differentially%20increased%20heart%20rate%20and%20blood%20pressure.%20These%20results%20may%20assist%20with%20dose%20finding%20for%20future%20psychedelic%20research.%22%2C%22date%22%3A%222022-05%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41386-022-01297-2%22%2C%22ISSN%22%3A%221740-634X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41386-022-01297-2%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22FRZ3YRB3%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Halberstadt%20and%20Geyer%22%2C%22parsedDate%22%3A%222011-09-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHalberstadt%2C%20A.%20L.%2C%20%26amp%3B%20Geyer%2C%20M.%20A.%20%282011%29.%20Multiple%20receptors%20contribute%20to%20the%20behavioral%20effects%20of%20indoleamine%20hallucinogens.%20%26lt%3Bi%26gt%3BNeuropharmacology%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B61%26lt%3B%5C%2Fi%26gt%3B%283%29%2C%20364%26%23x2013%3B381.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.neuropharm.2011.01.017%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.neuropharm.2011.01.017%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Multiple%20receptors%20contribute%20to%20the%20behavioral%20effects%20of%20indoleamine%20hallucinogens%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20L.%22%2C%22lastName%22%3A%22Halberstadt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20A.%22%2C%22lastName%22%3A%22Geyer%22%7D%5D%2C%22abstractNote%22%3A%22Serotonergic%20hallucinogens%20produce%20profound%20changes%20in%20perception%2C%20mood%2C%20and%20cognition.%20These%20drugs%20include%20phenylalkylamines%20such%20as%20mescaline%20and%202%2C5-dimethoxy-4-methylamphetamine%20%28DOM%29%2C%20and%20indoleamines%20such%20as%20%28%2B%29-lysergic%20acid%20diethylamide%20%28LSD%29%20and%20psilocybin.%20Despite%20their%20differences%20in%20chemical%20structure%2C%20the%20two%20classes%20of%20hallucinogens%20produce%20remarkably%20similar%20subjective%20effects%20in%20humans%2C%20and%20induce%20cross-tolerance.%20The%20phenylalkylamine%20hallucinogens%20are%20selective%205-HT2%20receptor%20agonists%2C%20whereas%20the%20indoleamines%20are%20relatively%20non-selective%20for%20serotonin%20%285-HT%29%20receptors.%20There%20is%20extensive%20evidence%2C%20from%20both%20animal%20and%20human%20studies%2C%20that%20the%20characteristic%20effects%20of%20hallucinogens%20are%20mediated%20by%20interactions%20with%20the%205-HT2A%20receptor.%20Nevertheless%2C%20there%20is%20also%20evidence%20that%20interactions%20with%20other%20receptor%20sites%20contribute%20to%20the%20psychopharmacological%20and%20behavioral%20effects%20of%20the%20indoleamine%20hallucinogens.%20This%20article%20reviews%20the%20evidence%20demonstrating%20that%20the%20effects%20of%20indoleamine%20hallucinogens%20in%20a%20variety%20of%20animal%20behavioral%20paradigms%20are%20mediated%20by%20both%205-HT2%20and%20non-5-HT2%20receptors.%22%2C%22date%22%3A%222011-09-01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.neuropharm.2011.01.017%22%2C%22ISSN%22%3A%220028-3908%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0028390811000207%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22I5JQRUQP%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Carbou%5Cu00e9%20and%20Lopez%22%2C%22parsedDate%22%3A%222021%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCarbou%26%23xE9%3B%2C%20Q.%2C%20%26amp%3B%20Lopez%2C%20M.%20%282021%29.%20Amanita%20muscaria%3A%20Ecology%2C%20chemistry%2C%20myths.%20%26lt%3Bi%26gt%3BEncyclopedia%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B1%26lt%3B%5C%2Fi%26gt%3B%283%29%2C%20905%26%23x2013%3B914.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.mdpi.com%5C%2F2673-8392%5C%2F1%5C%2F3%5C%2F69%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fwww.mdpi.com%5C%2F2673-8392%5C%2F1%5C%2F3%5C%2F69%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Amanita%20muscaria%3A%20Ecology%2C%20chemistry%2C%20myths%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Quentin%22%2C%22lastName%22%3A%22Carbou%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michel%22%2C%22lastName%22%3A%22Lopez%22%7D%5D%2C%22abstractNote%22%3A%22%28Available%20in%20free%20full%20text%29%20Amanita%20muscaria%20is%20the%20most%20emblematic%20mushroom%20in%20the%20popular%20representation.%20It%20is%20an%20ectomycorrhizal%20fungus%20endemic%20to%20the%20cold%20ecosystems%20of%20the%20northern%20hemisphere.%20The%20basidiocarp%20contains%20isoxazoles%20compounds%20that%20have%20specific%20actions%20on%20the%20central%20nervous%20system%2C%20including%20hallucinations.%20For%20this%20reason%2C%20it%20is%20considered%20an%20important%20entheogenic%20mushroom%20in%20different%20cultures%20whose%20remnants%20are%20still%20visible%20in%20some%20modern-day%20European%20traditions.%20In%20Siberian%20civilizations%2C%20it%20has%20been%20consumed%20for%20religious%20and%20recreational%20purposes%20for%20millennia%2C%20as%20it%20was%20the%20only%20inebriant%20in%20this%20region.%22%2C%22date%22%3A%222021%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%222673-8392%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.mdpi.com%5C%2F2673-8392%5C%2F1%5C%2F3%5C%2F69%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22LK2NPGQM%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hastings%22%2C%22parsedDate%22%3A%222006-09-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHastings%2C%20A.%20%282006%29.%20An%20Extended%20Nondrug%20MDMA-Like%20Experience%20Evoked%20Through%20Posthypnotic%20Suggestion.%20%26lt%3Bi%26gt%3BJournal%20of%20Psychoactive%20Drugs%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B38%26lt%3B%5C%2Fi%26gt%3B%283%29%2C%20273%26%23x2013%3B283.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F02791072.2006.10399853%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F02791072.2006.10399853%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22An%20Extended%20Nondrug%20MDMA-Like%20Experience%20Evoked%20Through%20Posthypnotic%20Suggestion%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arthur%22%2C%22lastName%22%3A%22Hastings%22%7D%5D%2C%22abstractNote%22%3A%22This%20research%20explored%20whether%20hypnotic%20suggestion%20could%20produce%20a%20subjective%20mindbody%20condition%20similar%20to%20that%20produced%20by%20the%20psychoactive%20drug%20methylenedioxy%20methamphetamine%20%28MDMA%2C%20Ecstasy%29.%20Twelve%20participants%20received%20posthypnotic%20instructions%20to%20re-experience%20an%20MDMA-like%20state%20posthypnotically%2C%20similar%20to%20one%20in%20their%20prior%20experience%2C%20for%20one%20hour.%20Three%20separate%20self%20report%20measures%20and%20qualitative%20self%20reports%20showed%20that%20the%20posthypnotic%20condition%20effectively%20mimicked%20an%20MDMA-like%20experience%2C%20lasting%20an%20hour%20at%20a%20stable%20level.%20Participant%20ratings%20in%20real%20time%20and%20in%20retrospect%20ranged%20from%2036%25%20to%20100%25%20similarity%20to%20a%20drug-induced%20experience.%20The%20qualitative%20reports%20and%20rating%20scales%20enabled%20a%20phenomenological%20description%20of%20the%20subjective%20experience.%20Scores%20on%20the%20Tellegen%20Absorption%20Scale%20correlated%20significantly%20with%20the%20strength%20of%20the%20posthypnotic%20condition%20%28Spearman%20rho%20.87%2C%20p%20%3D%20.0003%29.%20The%20participants%20successfully%20carried%20out%20various%20intentional%20activities%20during%20this%20time%20%28e.g.%2C%20self%20reflection%2C%20talking%20with%20partners%20about%20relationships%2C%20artwork%2C%20walking%20in%20nature%29.%20Applications%20for%20this%20technique%20as%20an%20adjunct%20to%20therapy%20and%20health%20treatments%20are%20discussed.%22%2C%22date%22%3A%22September%201%2C%202006%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1080%5C%2F02791072.2006.10399853%22%2C%22ISSN%22%3A%220279-1072%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F02791072.2006.10399853%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22NWW4NULC%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Castro%20Santos%20and%20Gama%20Marques%22%2C%22parsedDate%22%3A%222021-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCastro%20Santos%2C%20H.%2C%20%26amp%3B%20Gama%20Marques%2C%20J.%20%282021%29.%20What%20is%20the%20clinical%20evidence%20on%20psilocybin%20for%20the%20treatment%20of%20psychiatric%20disorders%3F%20A%20systematic%20review.%20%26lt%3Bi%26gt%3BPorto%20Biomedical%20Journal%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B6%26lt%3B%5C%2Fi%26gt%3B%281%29%2C%20e128.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2Fj.pbj.0000000000000128%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2Fj.pbj.0000000000000128%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22What%20is%20the%20clinical%20evidence%20on%20psilocybin%20for%20the%20treatment%20of%20psychiatric%20disorders%3F%20A%20systematic%20review%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Henrique%22%2C%22lastName%22%3A%22Castro%20Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jo%5Cu00e3o%22%2C%22lastName%22%3A%22Gama%20Marques%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%5Cu00a0%5Cn%20%20%20%20%20%20%20%20Psilocybin%20is%20a%20predominant%20agonist%20of%205HT1A%20and%205HT2A%5C%2FC%20receptors%20and%20was%20first%20isolated%20in%201958%2C%20shortly%20before%20it%20became%20a%20controlled%20substance.%20Research%20on%20the%20potential%20therapeutic%20effects%20of%20this%20compound%20has%20recently%20re-emerged%20alongside%20what%20is%20being%20addressed%20as%20a%20psychedelic%20renaissance.%5Cn%20%20%20%20%20%20%20%20Methods%3A%5Cu00a0%5Cn%20%20%20%20%20%20%20%20In%20this%20paper%20we%20performed%20a%20systematic%20review%20of%20the%20clinical%20trials%20conducted%20so%20far%20regarding%20the%20therapeutic%20effects%20of%20psilocybin%20on%20psychiatric%20disorders.%20The%20eligibility%20criteria%20included%20clinical%20trials%20that%20assessed%20psilocybin%26%23039%3Bs%20potential%20therapeutic%20effects%20on%20patients%20with%20psychiatric%20disorders.%20Nine%20hundred%20seven%20articles%20were%20found%20and%20screened%20in%20regard%20to%20the%20title%2C%20from%20which%2094%20were%20screened%20through%20abstract%20and%209%20met%20the%20eligibility%20criteria%20and%20were%20included.%5Cn%20%20%20%20%20%20%20%20Results%3A%5Cu00a0%5Cn%20%20%20%20%20%20%20%20The%20papers%20published%20focused%20on%203%20disorders%3A%20depression%2C%20obsessive-compulsive%20disorder%20%28OCD%29%20and%20substance%20use%20disorder%20%28namely%20tobacco%20and%20alcohol%29.%20Psilocybin%20has%20shown%20a%20relatively%20safe%20profile%20and%20very%20promising%20results%2C%20with%20reductions%20found%20on%20most%20of%20the%20psychiatric%20rating%20scales%5Cu2019%20scores.%20Research%20on%20depression%20showed%20the%20most%20solid%20evidence%2C%20supported%20by%203%20randomized%20controlled%20trials.%20Studies%20on%20OCD%20and%20substance%20use%20disorder%20showed%20more%20limitations%20due%20to%20their%20open-label%20design.%5Cn%20%20%20%20%20%20%20%20Conclusions%3A%5Cu00a0%5Cn%20%20%20%20%20%20%20%20Altogether%2C%20the%20results%20from%20the%20studies%20reviewed%20in%20this%20paper%20suggest%20a%20substantial%20therapeutic%20potential.%20This%20calls%20for%20further%20research%20to%20confirm%20the%20results%20observed%20so%20far%20and%20further%20explain%20the%20underlying%20mechanisms.%22%2C%22date%22%3A%22January%5C%2FFebruary%202021%22%2C%22language%22%3A%22en-US%22%2C%22DOI%22%3A%2210.1097%5C%2Fj.pbj.0000000000000128%22%2C%22ISSN%22%3A%222444-8664%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fjournals.lww.com%5C%2Fpbj%5C%2FFulltext%5C%2F2021%5C%2F02000%5C%2FWhat_is_the_clinical_evidence_on_psilocybin_for.22.aspx%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22IH9VJLBH%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Reavey%20et%20al.%22%2C%22parsedDate%22%3A%222018%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BReavey%2C%20P.%2C%20Boden%2C%20Z.%2C%20%26amp%3B%20Anderson%2C%20K.%20%282018%29.%20%26lt%3Bi%26gt%3BAn%20Affective%20%28Re%29balancing%20Act%3F%20The%20Liminal%20Possibilities%20for%20Heterosexual%20Partners%20on%20MDMA%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.researchgate.net%5C%2Fpublication%5C%2F322791658_An_Affective_Rebalancing_Act_The_Liminal_Possibilities_for_Heterosexual_Partners_on_MDMA%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fwww.researchgate.net%5C%2Fpublication%5C%2F322791658_An_Affective_Rebalancing_Act_The_Liminal_Possibilities_for_Heterosexual_Partners_on_MDMA%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22bookSection%22%2C%22title%22%3A%22An%20Affective%20%28Re%29balancing%20Act%3F%20The%20Liminal%20Possibilities%20for%20Heterosexual%20Partners%20on%20MDMA%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paula%22%2C%22lastName%22%3A%22Reavey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoe%22%2C%22lastName%22%3A%22Boden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katie%22%2C%22lastName%22%3A%22Anderson%22%7D%5D%2C%22abstractNote%22%3A%22The%20fact%20that%20MDMA%20%283%2C4-methylenedioxymethamphetamine%20or%20%5Cu2018ecstasy%5Cu2019%29%20has%20been%20dubbed%20the%20%5Cu2018love%20drug%5Cu2019%20and%20is%20notorious%20for%20making%20people%20feel%20%5Cu2018loved-up%5Cu2019%20invites%20the%20question%5Cu2014what%20is%20MDMA%5Cu2019s%20relationship%20to%20love%3F%20And%20how%20might%20MDMA%20use%20influence%20and%20intertwine%20with%20the%20experiences%20of%20people%20who%20love%20each%20other%3F%20Scholars%20have%20considered%20the%20way%20drug%20use%20is%20woven%20into%20the%20social%20fabric%20of%20people%5Cu2019s%20lives%20%28Farrugia%202015%3B%20Foster%20%26amp%3B%20Spencer%202013%29%20rather%20than%20an%20individualized%20phenomenon%20determined%20by%20pharmacology%2C%20which%2C%20arguably%2C%20has%20long%20dominated%20in%20the%20field%20of%20drugs%20research%20%28Foster%20%26amp%3B%20Spencer%202013%3B%20Moore%202008%29.%20%5CnHowever%2C%20explorations%20of%20complex%20social%20dynamics%20and%20drug%20use%20have%20been%20mainly%20limited%20to%20friendships%2C%20neglecting%20some%20of%20the%20key%20relationships%20in%20our%20lives%5Cu2014those%20of%20a%20romantic%20nature.%20We%20propose%20these%20intimate%20relationships%20can%20be%20productively%20understood%20through%20the%20lens%20of%20affective%20capacity%20%28Deleuze%201988%29.%20Affect%20allows%20us%20to%20focus%20on%20the%20less%20visible%20ways%20in%20which%20romantic%20partners%20relate%20to%20each%20other%2C%20and%20the%20capacity%20to%20affect%20and%20be%20affected%20enables%20us%20to%20shift%20away%20from%20the%20binary%20thought%20which%20has%20been%20used%20to%20define%20drug%20experiences%20as%2C%20for%20example%2C%20either%20harmful%20or%20unharmful%20%28Farrugia%202015%29%2C%20towards%20an%20experiential%20concern%20for%20how%20someone%20can%20be%20affected%20by%20the%20world%20around%20them.%5CnThis%20chapter%20will%20outline%20how%20we%20might%20consider%20differences%20between%20the%20expectations%20of%20men%20and%20women%20to%20comprise%20an%20affective%20inequality%20and%20how%20this%20can%20be%20partially%20rebalanced%20while%20together%20on%20MDMA.%20We%20will%20then%20focus%20on%20how%20tracing%20affect%20and%20affective%20capacity%20on%20MDMA%20can%20illuminate%20the%20relational%20effects%20of%20MDMA%20use%20and%20the%20extent%20to%20which%20this%20affective%20inequality%20might%20or%20might%20not%20be%20viewed%20as%20problematic%20by%20all%20couples%2C%20not%20just%20those%20who%20take%20MDMA%20together.%20These%20arguments%20owe%20much%20to%20feminist%20approaches%20which%20have%20prompted%20curiosity%20around%20gender%20inequality%2C%20manifested%20in%20women%20performing%20more%20emotional%20labour%20%28Erikson%201993%2C%202005%3B%20Hochschild%201983%29%20and%20household%20work%20including%20childcare%20and%20domestic%20chores%20%28Bianchi%20et%20al.%202000%3B%20Dryden%201999%3B%20Kan%2C%20Sullivan%20%26amp%3B%20Gershuny%202011%3B%20Lyonette%20%26amp%3B%20Crompton%202015%3B%20Mannino%20%26amp%3B%20Deutsch%202007%3B%20Pinto%20%26amp%3B%20Coltrane%202009%29%20than%20men.%20These%20concerns%20have%20largely%20been%20articulated%20in%20relation%20to%20heterosexual%20couples%3B%20same-sex%20couples%20tend%20to%20be%20more%20equal%20%28Connolly%202005%3B%20Gottman%202011%29%20and%20more%20emotionally%20attuned%20to%20one%20another%20%28Jonathan%202009%29.%20Hence%20we%20will%20draw%20only%20on%20data%20with%20heterosexual%20couples%20from%20the%20UK%2C%20EU%20and%20USA.%22%2C%22bookTitle%22%3A%22%22%2C%22date%22%3A%222018%22%2C%22language%22%3A%22%22%2C%22ISBN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.researchgate.net%5C%2Fpublication%5C%2F322791658_An_Affective_Rebalancing_Act_The_Liminal_Possibilities_for_Heterosexual_Partners_on_MDMA%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22FUMWWCGZ%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bonson%20and%20Murphy%22%2C%22parsedDate%22%3A%221995-12-15%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBonson%2C%20K.%20R.%2C%20%26amp%3B%20Murphy%2C%20D.%20L.%20%281995%29.%20Alterations%20in%20responses%20to%20LSD%20in%20humans%20associated%20with%20chronic%20administration%20of%20tricyclic%20antidepressants%2C%20monoamine%20oxidase%20inhibitors%20or%20lithium.%20%26lt%3Bi%26gt%3BBehavioural%20Brain%20Research%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B73%26lt%3B%5C%2Fi%26gt%3B%281%29%2C%20229%26%23x2013%3B233.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2F0166-4328%2896%2900102-7%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2F0166-4328%2896%2900102-7%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Alterations%20in%20responses%20to%20LSD%20in%20humans%20associated%20with%20chronic%20administration%20of%20tricyclic%20antidepressants%2C%20monoamine%20oxidase%20inhibitors%20or%20lithium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%20R.%22%2C%22lastName%22%3A%22Bonson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dennis%20L.%22%2C%22lastName%22%3A%22Murphy%22%7D%5D%2C%22abstractNote%22%3A%22This%20study%20sought%20to%20investigate%20possible%20interactions%20between%20antidepressant%20agents%20and%20lysergic%20acid%20diethylamide%20%28LSD%29%20in%20humans%20through%20the%20use%20of%20retrospective%20questionnaires.%20Ten%20subjects%20were%20identified%20who%20used%20LSD%20during%20chronic%20%283%20weeks%20or%20longer%29%20periods%20of%20antidepressant%20administration.%20These%20subjects%20were%20asked%20to%20desribe%20the%20phenomenological%20effects%20of%20self-administered%20hallucinogens%20prior%20to%20and%20during%20antidepressant%20treatment%3B%20a%20structured%2C%20standardized%20questionnaire%20was%20used%20to%20evaluate%20LSD%20experiences.%20Chronic%20tricylic%20antidepressant%20administration%20was%20associated%20with%20subjective%20increases%20in%20physical%2C%20hallucinatory%20and%20psychological%20responses%20to%20LSD.%20Similarly%2C%20subjects%20receiving%20lithium%20chronically%20also%20reported%20increases%20in%20their%20responses%20to%20LSD.%20In%20contrast%2C%20subjects%20who%20had%20been%20chronically%20taking%20an%20monoamine%20oxidase%20%28MAO%29%20inhibitor%20reported%20subjective%20decreases%20in%20the%20effects%20of%20LSD.%20This%20is%20similar%20to%20a%20previous%20report%20by%20our%20group%20of%20a%20decreased%20response%20to%20LSD%20in%20individuals%20who%20were%20chronically%20taking%20serotonin-selective%20antidepressants.%20These%20altered%20responses%20to%20LSD%20most%20likely%20involve%20differential%20changes%20in%20central%20serotonin%20and%20dopamine%20receptor%20systems%20and%20are%20consistent%20with%20other%20recent%20data%20suggesting%20that%20the%20clinical%20efficacy%20of%20different%20classes%20of%20antidepressants%20may%20not%20necessarily%20rely%20on%20a%20common%20mechanism%20of%20action%20in%20the%20brain.%22%2C%22date%22%3A%22December%2015%2C%201995%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2F0166-4328%2896%2900102-7%22%2C%22ISSN%22%3A%220166-4328%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2F0166432896001027%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22ZIAENC3L%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Parry%20and%20Buenz%22%2C%22parsedDate%22%3A%222018%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BParry%2C%20G.%20J.%2C%20%26amp%3B%20Buenz%2C%20E.%20J.%20%282018%29.%20Adventures%20in%20self%20experimentation.%20%26lt%3Bi%26gt%3BBr%20Med%20J%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B363%26lt%3B%5C%2Fi%26gt%3B%2C%20k5006.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmj.k5006%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmj.k5006%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Adventures%20in%20self%20experimentation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gareth%20J%22%2C%22lastName%22%3A%22Parry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20J%22%2C%22lastName%22%3A%22Buenz%22%7D%5D%2C%22abstractNote%22%3A%22Self%20experimentation%20is%20a%20rich%20medical%20tradition%2C%20leading%20to%20remarkable%20scientific%20advances%20but%20also%20erroneous%20conclusions%20and%2C%20sometimes%2C%20death.%20%20Recently%20we%20explored%20the%20properties%20of%20Urtica%20ferox%2C%20a%20stinging%20nettle%20endemic%20to%20New%20Zealand%20%28fig%201%29.%20During%20a%20collection%20expedition%20a%2071%20year%20old%20emeritus%20neurologist%20indulged%20in%20inadvertent%2C%20and%20subsequently%20deliberate%2C%20self%20experimentation.%20His%20notes%20of%20the%20evolving%20neurological%20manifestations%20after%20exposure%20provide%20clues%20to%20the%20toxin%5Cu2019s%20mechanism%20of%20action%20that%20would%20be%20difficult%20to%20draw%20without%20self%20experimentation.%20%20Self%20experimentation%20through%20the%20years%3A%20%20Historically%2C%20self%20experimentation%20was%20an%20important%20part%20of%20the%20scientific%20process%2C%20allowing%20medical%20advances%20that%20would%20have%20been%20hard%20to%20achieve%20otherwise%20because%20no%20sane%20human%20would%20agree%20to%20be%20a%20research%20participant%20and%20no%20ethical%20review%20board%20in%20its%20right%20mind%20would%20approve%20the%20experiment%20%5Cu2026%20.%20.%20.%20and%20in%20the%20future%3A%20%20We%20should%20acknowledge%20the%20value%20of%20self%20experimentation%20and%20bring%20it%20out%20from%20the%20shadows.%20However%2C%20the%20business%20world%20has%20long%20appreciated%20the%20risks%20associated%20with%20ego%20driven%20decisions15%20and%20%5Cu201cimportantitis%5Cu201d16%3A%20it%5Cu2019s%20unlikely%20that%20physicians%20and%20medical%20scientists%20are%20immune%20to%20ego%20clouding%20their%20clarity%20when%20deciding%20to%20self%20experiment.%20While%20ethics%20approval%20should%20be%20optional%20when%20people%20want%20to%20do%20this%2C14%20ethics%20committees%20and%20the%20soon-to-be%20participant%20should%20welcome%20an%20objective%2C%20unbiased%20review%20of%20the%20proposed%20self%20experiment%3A%20such%20a%20review%20can%20only%20help%20to%20ensure%20that%20the%20experiment%20is%20well%20designed.%20%20A%20comprehensive%20review%20showed%20that%20only%20around%202%25%20of%20documented%20efforts%20are%20made%20by%20women.17%20Consider%20the%20M%5Cu0101ori%20culture%5Cu2019s%20powhiri%20%28traditional%20meeting%20between%20groups%29%2C%20where%20the%20men%20sit%20in%20the%20first%20row%20and%20the%20women%20sit%20behind%20them18%3A%20the%20historical%20reasoning%20is%20that%2C%20if%20battle%20ensues%2C%20the%20men%5Cu2014less%20important%20in%20maintaining%20the%20family%20lineage%5Cu2014are%20the%20first%20in%20line%20to%20die.%20While%2089%25%20of%20self%20experiments%20ultimately%20support%20the%20hypothesis%20being%20tested%2C17%20the%20yellow%20fever%20and%20scurvy%20experiments%20show%20that%20the%20participant%20may%20be%20correct%5Cu2014but%20still%20dead.%20The%20sex%20bias%20in%20self%20experimentation%20could%20be%20the%20result%20of%20evolutional%20unimportance%20in%20males%2C%20a%20greater%20tendency%20towards%20narcissism%20in%20males%2C19%20or%20simply%20historical%20gender%20disparities%20in%20science%20and%20medicine.%20%20Self%20experimentation%20is%20not%20without%20its%20hazards%2C%20but%20it%20often%20leads%20to%20useful%20and%20timesaving%20medical%20advances%2C%20as%20in%20our%20investigations%20into%20stinging%20nettles.%20Formal%20investigation%20of%20exposure%20to%20the%20potential%20neurotoxin%20in%20U%20ferox%20would%20require%20isolation%20and%20identification%20of%20the%20active%20compound%2C%20as%20well%20as%20extensive%20preclinical%20characterisation%20and%20ethics%20approval%20to%20administer%20it%20to%20humans.%20If%20an%20old%20curmudgeon%20would%20like%20to%20inject%20himself%20with%20a%20neurotoxin%20for%20the%20sake%20of%20science%2C%20describing%20the%20process%20in%20exquisite%20detail%2C%20he%20should%20be%20thanked%20and%20presented%20with%20an%20award%5Cu2014ideally%20in%20large%20type%2C%20suitable%20for%20framing.%22%2C%22date%22%3A%222018%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmj.k5006%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.bmj.com%5C%2Fcontent%5C%2Fbmj%5C%2F363%5C%2Fbmj.k5006.full.pdf%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22DRLVTFXN%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Papaseit%20et%20al.%22%2C%22parsedDate%22%3A%222018-03%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BPapaseit%2C%20E.%2C%20Farr%26%23xE9%3B%2C%20M.%2C%20P%26%23xE9%3Brez-Ma%26%23xF1%3B%26%23xE1%3B%2C%20C.%2C%20Torrens%2C%20M.%2C%20Ventura%2C%20M.%2C%20Pujadas%2C%20M.%2C%20de%20la%20Torre%2C%20R.%2C%20%26amp%3B%20Gonz%26%23xE1%3Blez%2C%20D.%20%282018%29.%20Acute%20Pharmacological%20Effects%20of%202C-B%20in%20Humans%3A%20An%20Observational%20Study.%20%26lt%3Bi%26gt%3BFrontiers%20in%20Pharmacology%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B9%26lt%3B%5C%2Fi%26gt%3B%28206%29.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffphar.2018.00206%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffphar.2018.00206%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Acute%20Pharmacological%20Effects%20of%202C-B%20in%20Humans%3A%20An%20Observational%20Study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Esther%22%2C%22lastName%22%3A%22Papaseit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mag%5Cu00ed%22%2C%22lastName%22%3A%22Farr%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clara%22%2C%22lastName%22%3A%22P%5Cu00e9rez-Ma%5Cu00f1%5Cu00e1%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marta%22%2C%22lastName%22%3A%22Torrens%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mireia%22%2C%22lastName%22%3A%22Ventura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mitona%22%2C%22lastName%22%3A%22Pujadas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rafael%22%2C%22lastName%22%3A%22de%20la%20Torre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D%5Cu00e9bora%22%2C%22lastName%22%3A%22Gonz%5Cu00e1lez%22%7D%5D%2C%22abstractNote%22%3A%22%28Available%20in%20free%20full%20text%29%202%2C5-dimethoxy-4-bromophenethylamine%20%282C-B%29%20is%20a%20psychedelic%20phenylethylamine%20derivative%2C%20structurally%20similar%20to%20mescaline.%20It%20is%20a%20serotonin%205-hydroxytryptamine-2A%20%285-HT2A%29%2C%205-hydroxytryptamine-2B%20%285-HT2B%29%20and%205-hydroxytryptamine-2C%20%285-HT2C%29%20receptor%20partial%20agonist%20used%20recreationally%20as%20a%20new%20psychoactive%20substance%20%28NPS%29.%20It%20has%20been%20reported%20that%202C-B%20induces%20mild%20psychedelic%20effects%2C%20although%20its%20acute%20pharmacological%20effects%20and%20pharmacokinetics%20have%20not%20yet%20been%20fully%20studied%20in%20humans.%20An%20observational%20study%20was%20conducted%20to%20assess%20the%20acute%20subjective%20and%20physiological%20effects%2C%20as%20well%20as%20pharmacokinetics%20of%202C-B.%20Sixteen%20healthy%2C%20experienced%20drug%20users%20self-administered%20an%20oral%20dose%20of%202C-B%20%2810%2C%2015%2C%20or%2020%20mg%29.%20Vital%20signs%20%28blood%20pressure%20and%20heart%20rate%29%20were%20measured%20at%20baseline%201%2C%202%2C%203%2C%204%2C%20and%206%20hours%20%28h%29.%20Each%20participant%20completed%20subjective%20effects%20using%20three%20rating%20scales%3A%20Visual%20Analogue%20Scales%20%28VAS%29%2C%20the%20Addiction%20Research%20Centre%20Inventory%20%28ARCI%29%2C%20and%20Evaluation%20of%20the%20Subjective%20Effects%20of%20Substances%20with%20Abuse%20Potential%20%28VESSPA-SSE%29%20at%20baseline%2C%202-3%20h%2C%20and%206%20h%20after%20self-administration%20%28maximum%20effects%20along%206%20h%29%2C%20and%20the%20Hallucinogenic%20Rating%20Scale%20%28HRS%29%20%28maximum%20effects%20along%206%20h%29.%20Oral%20fluid%20%28saliva%29%20was%20collected%20to%20assess%202C-B%20and%20cortisol%20concentrations%20during%2024%20h.%20Acute%20administration%20of%202C-B%20increased%20blood%20pressure%20and%20heart%20rate.%20Scores%20of%20scales%20related%20to%20euphoria%20increased%20%28high%2C%20liking%20and%20stimulated%29%2C%20and%20changes%20in%20perceptions%20%28distances%2C%20colors%2C%20shapes%20and%20lights%29%20and%20different%20body%20feelings%5C%2Fsurrounding%20were%20produced.%20Mild%20hallucinating%20effects%20were%20described%20in%205%20subjects.%20Maximum%20concentrations%20of%202C-B%20and%20cortisol%20were%20reached%20at%201%20h%20and%203%20h%20after%20self-administration%2C%20respectively.%20Oral%202C-B%20at%20recreational%20doses%20induces%20a%20constellation%20of%20psychedelic%5C%2Fpsychostimulant-like%20effects%20similar%20to%20those%20associated%20with%20serotonin-acting%20drugs.%22%2C%22date%22%3A%222018-March-13%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.3389%5C%2Ffphar.2018.00206%22%2C%22ISSN%22%3A%221663-9812%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.frontiersin.org%5C%2Farticle%5C%2F10.3389%5C%2Ffphar.2018.00206%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22YDUGPGW4%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Borissova%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBorissova%2C%20A.%2C%20Ferguson%2C%20B.%2C%20Wall%2C%20M.%20B.%2C%20Morgan%2C%20C.%20J.%2C%20Carhart-Harris%2C%20R.%20L.%2C%20Bolstridge%2C%20M.%2C%20Bloomfield%2C%20M.%20A.%2C%20Williams%2C%20T.%20M.%2C%20Feilding%2C%20A.%2C%20Murphy%2C%20K.%2C%20Tyacke%2C%20R.%20J.%2C%20Erritzoe%2C%20D.%2C%20Stewart%2C%20L.%2C%20Wolff%2C%20K.%2C%20Nutt%2C%20D.%2C%20Curran%2C%20H.%20V.%2C%20%26amp%3B%20Lawn%2C%20W.%20%282020%29.%20Acute%20effects%20of%20MDMA%20on%20trust%2C%20cooperative%20behaviour%20and%20empathy%3A%20A%20double-blind%2C%20placebo-controlled%20experiment.%20%26lt%3Bi%26gt%3BJournal%20of%20Psychopharmacology%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B0%26lt%3B%5C%2Fi%26gt%3B%280%29%2C%200269881120926673.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1177%5C%2F0269881120926673%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1177%5C%2F0269881120926673%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Acute%20effects%20of%20MDMA%20on%20trust%2C%20cooperative%20behaviour%20and%20empathy%3A%20A%20double-blind%2C%20placebo-controlled%20experiment%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22Borissova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bart%22%2C%22lastName%22%3A%22Ferguson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20B%22%2C%22lastName%22%3A%22Wall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Celia%20JA%22%2C%22lastName%22%3A%22Morgan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robin%20L%22%2C%22lastName%22%3A%22Carhart-Harris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Bolstridge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20AP%22%2C%22lastName%22%3A%22Bloomfield%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tim%20M%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%22%2C%22lastName%22%3A%22Feilding%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22Murphy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robin%20J%22%2C%22lastName%22%3A%22Tyacke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Erritzoe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorna%22%2C%22lastName%22%3A%22Stewart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kim%22%2C%22lastName%22%3A%22Wolff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Nutt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H%20Valerie%22%2C%22lastName%22%3A%22Curran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Will%22%2C%22lastName%22%3A%22Lawn%22%7D%5D%2C%22abstractNote%22%3A%22%28Available%20in%20free%20full%20text%29%20Background%3A%203%2C4-Methylenedioxymethamphetamine%20%28MDMA%29%20is%20being%20actively%20researched%20as%20an%20adjunct%20to%20psychotherapy.%20It%20may%20be%20beneficial%20to%20trust%2C%20empathy%20and%20cooperative%20behaviour%20due%20to%20its%20acute%20prosocial%20effects.Aim%3ATo%20test%20%28a%29%20the%20acute%20effects%20of%20MDMA%20on%20measures%20of%20empathy%2C%20trust%20and%20cooperative%20behaviour%2C%20and%20%28b%29%20subacute%20changes%20in%20mood%20three%20days%20after%20MDMA%20administration.%20Methods%3ATwenty-five%20participants%20%28n%3D7%20female%29%2C%20participated%20in%20this%20double-blind%2C%20repeated-measures%2C%20placebo-controlled%20experiment.%20Participants%20attended%20two%20acute%20sessions%2C%20one%20week%20apart.%20Each%20acute%20session%20was%20followed%20by%20a%20subacute%20session%20three%20days%20later.%20Participants%20received%20placebo%20%28100%5Cu2009mg%20ascorbic%20acid%29%20during%20one%20acute%20session%2C%20and%20MDMA%20%28100%5Cu2009mg%20MDMA-HCl%29%20at%20the%20other%2C%20with%20order%20counterbalanced.%20Participants%20completed%20the%20following%20tasks%20assessing%20prosocial%20behaviour%3A%20a%20trust%20investment%20task%2C%20a%20trustworthy%20face%20rating%20task%2C%20an%20empathic%20stories%20task%2C%20a%20public%20project%20game%2C%20a%20dictator%20game%20and%20an%20ultimatum%20game.%20Participants%20reported%20subjective%20effects.%20Blood%20was%20taken%20pre-drug%2C%202%20and%204%20hours%20post-drug%2C%20and%20tested%20for%20plasma%20MDMA%20levels.Results%3AMDMA%20acutely%20increased%20self-reported%20%5Cu2018closeness%20to%20others%5Cu2019%20and%20%5Cu2018euphoria%5Cu2019%20and%20increased%20plasma%20concentrations%20of%20MDMA.%20MDMA%20did%20not%20significantly%20change%20task-based%20empathy%2C%20trust%20or%20cooperative%20behaviour.%20Using%20Bayesian%20analyses%2C%20we%20found%20evidence%20that%20MDMA%20and%20placebo%20did%20not%20differ%20in%20their%20effects%20on%20empathy%20and%20cooperative%20behaviour.%20MDMA%20did%20not%20significantly%20change%20subacute%20mood%20and%20this%20was%20supported%20by%20our%20Bayesian%20analyses.Conclusion%3ADespite%20augmentation%20in%20plasma%20MDMA%20levels%20and%20subjective%20drug%20effects%2C%20we%20found%20no%20increase%20in%20prosocial%20behaviour%20in%20a%20laboratory%20setting.%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1177%5C%2F0269881120926673%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fjournals.sagepub.com%5C%2Fdoi%5C%2Fabs%5C%2F10.1177%5C%2F0269881120926673%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%225PMDVCIP%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bouso%20et%20al.%22%2C%22parsedDate%22%3A%222013-12%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBouso%2C%20J.%20C.%2C%20Fabregas%2C%20J.%20M.%2C%20Antonijoan%2C%20R.%20M.%2C%20Rodriguez-Fornells%2C%20A.%2C%20%26amp%3B%20Riba%2C%20J.%20%282013%29.%20Acute%20effects%20of%20ayahuasca%20on%20neuropsychological%20performance%3A%20differences%20in%20executive%20function%20between%20experienced%20and%20occasional%20users.%20%26lt%3Bi%26gt%3BPsychopharmacology%20%28Berl%29%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B230%26lt%3B%5C%2Fi%26gt%3B%283%29%2C%20415%26%23x2013%3B424.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00213-013-3167-9%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00213-013-3167-9%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Acute%20effects%20of%20ayahuasca%20on%20neuropsychological%20performance%3A%20differences%20in%20executive%20function%20between%20experienced%20and%20occasional%20users%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20C.%22%2C%22lastName%22%3A%22Bouso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20M.%22%2C%22lastName%22%3A%22Fabregas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20M.%22%2C%22lastName%22%3A%22Antonijoan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Rodriguez-Fornells%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Riba%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Ayahuasca%2C%20a%20South%20American%20psychotropic%20plant%20tea%20containing%20the%20psychedelic%205-HT2A%20receptor%20agonist%20N%2CN-dimethyltryptamine%2C%20has%20been%20shown%20to%20increase%20regional%20cerebral%20blood%20flow%20in%20prefrontal%20brain%20regions%20after%20acute%20administration%20to%20humans.%20Despite%20interactions%20at%20this%20level%2C%20neuropsychological%20studies%20have%20not%20found%20cognitive%20deficits%20in%20abstinent%20long-term%20users.%20OBJECTIVES%3A%20Here%2C%20we%20wished%20to%20investigate%20the%20effects%20of%20acute%20ayahuasca%20intake%20on%20neuropsychological%20performance%2C%20specifically%20on%20working%20memory%20and%20executive%20function.%20METHODS%3A%20Twenty-four%20ayahuasca%20users%20%2811%20long-term%20experienced%20users%20and%2013%20occasional%20users%29%20were%20assessed%20in%20their%20habitual%20setting%20using%20the%20Stroop%2C%20Sternberg%2C%20and%20Tower%20of%20London%20tasks%20prior%20to%20and%20following%20ayahuasca%20intake.%20RESULTS%3A%20Errors%20in%20the%20Sternberg%20task%20increased%2C%20whereas%20reaction%20times%20in%20the%20Stroop%20task%20decreased%20and%20accuracy%20was%20maintained%20for%20the%20whole%20sample%20following%20ayahuasca%20intake.%20Interestingly%2C%20results%20in%20the%20Tower%20of%20London%20showed%20significantly%20increased%20execution%20and%20resolution%20times%20and%20number%20of%20movements%20for%20the%20occasional%20but%20not%20the%20experienced%20users.%20Additionally%2C%20a%20correlation%20analysis%20including%20all%20subjects%20showed%20that%20impaired%20performance%20in%20the%20Tower%20of%20London%20was%20inversely%20correlated%20with%20lifetime%20ayahuasca%20use.%20CONCLUSIONS%3A%20Acute%20ayahuasca%20administration%20impaired%20working%20memory%20but%20decreased%20stimulus-response%20interference.%20Interestingly%2C%20detrimental%20effects%20on%20higher%20cognition%20were%20only%20observed%20in%20the%20less%20experienced%20group.%20Rather%20than%20leading%20to%20increased%20impairment%2C%20greater%20prior%20exposure%20to%20ayahuasca%20was%20associated%20with%20reduced%20incapacitation.%20Compensatory%20or%20neuromodulatory%20effects%20associated%20with%20long-term%20ayahuasca%20intake%20could%20underlie%20preserved%20executive%20function%20in%20experienced%20users.%22%2C%22date%22%3A%222013%20Dec%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00213-013-3167-9%22%2C%22ISSN%22%3A%221432-2072%20%28Electronic%29%200033-3158%20%28Linking%29%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F23793226%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22RLS7XW2Y%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zheng%20et%20al.%22%2C%22parsedDate%22%3A%222020-03-15%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BZheng%2C%20W.%2C%20Cai%2C%20D.-B.%2C%20Xiang%2C%20Y.-Q.%2C%20Zheng%2C%20W.%2C%20Jiang%2C%20W.-L.%2C%20Sim%2C%20K.%2C%20Ungvari%2C%20G.%20S.%2C%20Huang%2C%20X.%2C%20Huang%2C%20X.-X.%2C%20Ning%2C%20Y.-P.%2C%20%26amp%3B%20Xiang%2C%20Y.-T.%20%282020%29.%20Adjunctive%20intranasal%20esketamine%20for%20major%20depressive%20disorder%3A%20A%20systematic%20review%20of%20randomized%20double-blind%20controlled-placebo%20studies.%20%26lt%3Bi%26gt%3BJournal%20of%20Affective%20Disorders%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B265%26lt%3B%5C%2Fi%26gt%3B%2C%2063%26%23x2013%3B70.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jad.2020.01.002%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jad.2020.01.002%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Adjunctive%20intranasal%20esketamine%20for%20major%20depressive%20disorder%3A%20A%20systematic%20review%20of%20randomized%20double-blind%20controlled-placebo%20studies%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Zheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dong-Bin%22%2C%22lastName%22%3A%22Cai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ying-Qiang%22%2C%22lastName%22%3A%22Xiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Zheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wen-Long%22%2C%22lastName%22%3A%22Jiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kang%22%2C%22lastName%22%3A%22Sim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabor%20S.%22%2C%22lastName%22%3A%22Ungvari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiong%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xing-Xiao%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-Ping%22%2C%22lastName%22%3A%22Ning%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-Tao%22%2C%22lastName%22%3A%22Xiang%22%7D%5D%2C%22abstractNote%22%3A%22Objectives%20This%20is%20a%20meta-analysis%20of%20randomized%20double-blind%20controlled-placebo%20trials%20%28RCTs%29%20examining%20the%20effectiveness%2C%20tolerability%2C%20and%20safety%20of%20intranasal%20esketamine%20in%20treating%20major%20depressive%20disorder%20%28MDD%29.%20Methods%20Standardized%20mean%20difference%20%28SMD%29%2C%20risk%20ratio%20%28RR%29%20and%20their%2095%25%20confidence%20intervals%20%28CIs%29%20were%20calculated%20using%20RevMan%20version%205.3.%20Results%20Four%20RCTs%20with%207%20active%20arms%20covering%20708%20patients%20with%20MDD%20on%20intranasal%20esketamine%20%28n%5Cu00a0%3D%5Cu00a0419%29%20and%20placebo%20%28n%5Cu00a0%3D%5Cu00a0289%29%20were%20included.%20Compared%20with%20placebo%2C%20adjunctive%20intranasal%20esketamine%20was%20associated%20with%20significantly%20greater%20study-defined%20response%20%28RR%3D1.39%2C%2095%25CI%3A%201.18%20to%201.64%2C%20P%26lt%3B0.0001%29%20and%20remission%20%28RR%3D1.42%2C%2095%25CI%3A%201.17%20to%201.72%2C%20P%5Cu00a0%3D%5Cu00a00.0004%29%20at%20endpoint%20assessment.%20Intranasal%20esketamine%20had%20greater%20study-defined%20response%20starting%20at%202%5Cu00a0h%20%28RR%3D%5Cu00a02.77%2C%2095%25CI%3A%201.62%20to%204.76%2C%20P%5Cu00a0%3D%5Cu00a00.0002%29%2C%20peaking%20at%2024%5Cu00a0h%20%28RR%3D5.42%2C%2095%25CI%3A%201.38%20to%2021.20%2C%20P%5Cu00a0%3D%5Cu00a00.02%29%2C%20and%20at%20least%20lasting%20for%2028%20days%20%28RR%3D1.36%2C%2095%25CI%3A%201.16%20to%201.58%2C%20P%5Cu00a0%3D%5Cu00a00.0001%29.%20Similarly%2C%20intranasal%20esketamine%20had%20significantly%20greater%20study-defined%20remission%20starting%20at%202%5Cu00a0h%20%28RR%3D7.71%2C%2095%25CI%3A%202.16%20to%2027.55%2C%20P%5Cu00a0%3D%5Cu00a00.002%29%2C%20peaking%20at%2024%5Cu00a0h%20%28RR%3D6.87%2C%2095%25CI%3A%201.55%20to%2030.35%2C%20P%5Cu00a0%3D%5Cu00a00.01%29%2C%20and%20lasting%20for%2028%20days%20%28RR%3D1.38%2C%2095%25CI%3A%201.11%20to%201.72%2C%20P%5Cu00a0%3D%5Cu00a00.004%29.%20Intranasal%20esketamine%20had%20a%20significantly%20higher%20rate%20of%20discontinuation%20due%20to%20intolerability%20%28RR%3D3.50%2C%2095%25CI%3A%201.38%20to%208.86%2C%20P%5Cu00a0%3D%5Cu00a00.008%29.%20Discontinuation%20due%20to%20any%20reasons%20and%20inefficacy%20were%20similar%20between%20the%20two%20groups.%20Conclusion%20Intranasal%20esketamine%20appears%20to%20have%20an%20ultra-rapid%20antidepressant%20effect%20for%20MDD%2C%20at%20least%20lasting%20for%2028%20days.%20The%20long-term%20therapeutic%20effect%20and%20safety%20of%20intranasal%20esketamine%20need%20to%20be%20further%20examined%20in%20large-scale%20RCTs.%22%2C%22date%22%3A%22March%2015%2C%202020%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jad.2020.01.002%22%2C%22ISSN%22%3A%220165-0327%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0165032719327272%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22ZHGJMBBJ%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Michael%20et%20al.%22%2C%22parsedDate%22%3A%222021%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMichael%2C%20P.%2C%20Luke%2C%20D.%2C%20%26amp%3B%20Robinson%2C%20O.%20%282021%29.%20An%20Encounter%20with%20the%20Other%3A%20A%20Thematic%20Analysis%20of%20Accounts%20of%20DMT%20Experiences%20from%20a%20Naturalistic%20Field%20Study.%20%26lt%3Bi%26gt%3BPsyArXiv%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.31234%5C%2Fosf.io%5C%2F8cdgs%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.31234%5C%2Fosf.io%5C%2F8cdgs%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22An%20Encounter%20with%20the%20Other%3A%20A%20Thematic%20Analysis%20of%20Accounts%20of%20DMT%20Experiences%20from%20a%20Naturalistic%20Field%20Study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Michael%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Luke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%22%2C%22lastName%22%3A%22Robinson%22%7D%5D%2C%22abstractNote%22%3A%22%28Available%20in%20free%20full%20text%29%20Introduction%3A%20N%2C%20N-Dimethyltryptamine%20%28DMT%29%20is%20an%20endogenous%20serotonergic%20psychedelic%20capable%20of%20producing%20radical%20shifts%20in%20conscious%20experience.%20Increasing%20trends%20in%20its%20use%2C%20as%20well%20as%20new%20trials%20administering%20DMT%20to%20patients%2C%20indicate%20the%20growing%20importance%20of%20a%20thorough%20elucidation%20of%20the%20phenomenology%20the%20drug%20may%20occasion.%20This%20is%20particularly%20in%20light%20of%20the%20hyper-real%2C%20otherworldly%2C%20and%20often%20ontologically%20challenging%20yet%20potentially%20transformative%2C%20nature%20of%20the%20experience%2C%20not%20least%20encounters%20with%20apparently%20non-self%20social%20agents.%20Laboratory%20studies%20have%20been%20limited%20by%20clinical%20setting%20and%20lacking%20qualitative%20analyses%2C%20while%20online%20surveys%5Cu2019%20limitations%20lie%20in%20retrospective%20design%2C%20recreational%20use%2C%20and%20both%20of%20which%20not%20guaranteeing%20%5Cu2018breakthrough%5Cu2019%20experiences.%20Methods%3A%20We%20report%20on%20the%20first%20naturalistic%20field%20study%20of%20DMT%20use%20including%20its%20qualitative%20analysis.%20Screened%2C%20healthy%2C%20anonymised%20and%20experienced%20DMT%20users%20%2840-75mg%20inhaled%29%20were%20observed%20during%20their%20non-clinical%20use%20of%20the%20drug%20at%20home.%20Semi-structured%20interviews%20using%20the%20micro-phenomenological%20technique%20were%20employed%20immediately%20after%20their%20experience.%20This%20paper%20reports%20on%20the%20thematic%20analysis%20of%20one%20major%20domain%20of%20the%20breakthrough%20experiences%20elicited%3B%20the%20%5Cu2018other%5Cu2019.%20Thirty-six%20post-DMT%20experience%20interviews%20with%20mostly%20Caucasian%20%2883%25%29%20males%20%288%20female%29%20of%20average%2037%20years%20were%20predominantly%20inductively%20coded.%20Results%3A%20Invariably%2C%20profound%20and%20highly%20intense%20experiences%20occurred.%20The%20main%20overarching%20category%20comprised%20the%20encounter%20with%20other%20%5Cu2018beings%5Cu2019%20%2894%25%20of%20reports%29%2C%20with%20further%20subordinate%20themes%20including%20the%20entities%5Cu2019%20role%2C%20appearance%2C%20demeanour%2C%20communication%20and%20interaction%3B%20while%20the%20other%20over-arching%20category%20comprised%20experiences%20of%20emerging%20into%20other%20%5Cu2018worlds%5Cu2019%20%28100%25%20of%20reports%29%2C%20in%20turn%20consisting%20of%20the%20scene%2C%20the%20content%20and%20quality%20of%20the%20immersive%20spaces.%20Discussion%3A%20The%20present%20study%20provides%20a%20systematic%20and%20in-depth%20analysis%20of%20the%20features%20of%20the%20otherworldly%20encounter%20within%20the%20breakthrough%20DMT%20experience%2C%20as%20well%20as%20elaborating%20on%20the%20resonances%20with%20both%20previous%20DMT%20studies%20and%20other%20types%20of%20extraordinary%20experiences%20which%20also%20entail%20entity%20encounters.%20These%20include%20the%20alien%20abduction%2C%20folkloric%2C%20shamanic%20and%20near-death%20experience.%20Putative%20neural%20mechanisms%20of%20these%20features%20of%20the%20DMT%20experience%20and%20its%20promise%20as%20a%20psychotherapeutic%20agent%20are%20discussed%20in%20light%20of%20such%20findings.%22%2C%22date%22%3A%222021%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.31234%5C%2Fosf.io%5C%2F8cdgs%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22IFDUHWFF%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Davenport%22%2C%22parsedDate%22%3A%222021-04-14%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BDavenport%2C%20L.%20%282021%29.%20%26lt%3Bi%26gt%3BAdjunctive%20MDMA%20safe%2C%20effective%20for%20severe%20PTSD%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.medscape.com%5C%2Fviewarticle%5C%2F949243%3Fsrc%3DWNL_mdpls_210416_mscpedit_psych%26amp%3Buac%3D25072MJ%26amp%3Bspon%3D12%26amp%3BimpID%3D3315763%26amp%3Bfaf%3D1%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fwww.medscape.com%5C%2Fviewarticle%5C%2F949243%3Fsrc%3DWNL_mdpls_210416_mscpedit_psych%26amp%3Buac%3D25072MJ%26amp%3Bspon%3D12%26amp%3BimpID%3D3315763%26amp%3Bfaf%3D1%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Adjunctive%20MDMA%20safe%2C%20effective%20for%20severe%20PTSD%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liam%22%2C%22lastName%22%3A%22Davenport%22%7D%5D%2C%22abstractNote%22%3A%22Adding%203%2C4-methylenedioxymethamphetamine%20%28MDMA%29%20to%20integrative%20psychotherapy%20may%20significantly%20improve%20symptoms%20and%20well-being%20for%20patients%20with%20severe%20posttraumatic%20stress%20disorder%20%28PTSD%29%2C%20including%20those%20with%20the%20dissociative%20subtype%2C%20new%20research%20suggests.%20%20MAPP1%20is%20the%20first%20phase%203%20randomized%20controlled%20trial%20of%20MDMA-assisted%20therapy%20in%20this%20population.%20Participants%20who%20received%20the%20active%20treatment%20showed%20greater%20improvement%20in%20PTSD%20symptoms%2C%20mood%2C%20and%20empathy%20in%20comparison%20with%20participants%20who%20received%20placebo.%20%20MDMA%20was%20%26quot%3Bextremely%20effective%2C%20particularly%20for%20a%20subpopulation%20that%20ordinarily%20does%20not%20respond%20well%20to%20conventional%20treatment%2C%26quot%3B%20study%20co-investigator%20Bessel%20van%20der%20Kolk%2C%20MD%2C%20professor%20of%20psychiatry%20at%20Boston%20University%20School%20of%20Medicine%2C%20Boston%2C%20Massachusetts%2C%20told%20delegates%20attending%20the%20virtual%20European%20Psychiatric%20Association%20%28EPA%29%202021%20Congress.%5Cn%5CnGrowing%20Interest%5CnIn%20recent%20years%2C%20there%20has%20been%20a%20great%20deal%20of%20interest%20in%20the%20potential%20of%20MDMA%20for%20the%20treatment%20of%20PTSD%2C%20particularly%20because%20failure%20rates%20with%20most%20available%20evidence-based%20treatments%20have%20been%20relatively%20high.%20%20As%20previously%20reported%20by%20Medscape%20Medical%20News%2C%20in%202017%2C%20the%20US%20Food%20and%20Drug%20Administration%20approved%20the%20trial%20design%20of%20Kolk%26%23039%3Bs%20and%20colleagues%26%23039%3B%20MAPP1%20study%20after%20granting%20MDMA%20breakthrough%20designation.%20%20The%20MAPP1%20investigators%20assessed%2090%20patients%20with%20PTSD%20%28mean%20age%2C%2041%20years%3B%2077%25%20White%3B%2066%25%20women%29%20from%2050%20sites.%20For%20the%20majority%20of%20patients%20%2884%25%29%2C%20trauma%20history%20was%20developmental.%20%26quot%3BIn%20other%20words%2C%20trauma%20%5Boccurred%5D%20very%20early%20in%20life%2C%20usually%20at%20the%20hands%20of%20their%20own%20caregivers%2C%26quot%3B%20Kolk%20noted.%20%20In%20addition%2C%2018%25%20of%20the%20patients%20were%20veterans%2C%20and%2012%25%20had%20combat%20exposure.%20The%20average%20duration%20of%20PTSD%20before%20enrollment%20was%2018%20years.%20All%20patients%20underwent%20screening%20and%20three%20preparatory%20psychotherapy%20sessions%20at%20enrollment.%20%20Participants%20were%20randomly%20assigned%20to%20receive%20MDMA%2080%20mg%20or%20120%20mg%20%28n%20%3D%2046%29%20or%20placebo%20%28n%20%3D%2044%29%20followed%20by%20three%20integrative%20psychotherapy%20sessions%20lasting%20a%20total%20of%208%20hours.%20A%20supplemental%20dose%20of%2040%20or%2060%20mg%20of%20MDMA%20could%20be%20administered%20from%201.5%20to%202%20hours%20after%20the%20first%20dose.%20%20The%20patients%20stayed%20in%20the%20laboratory%20on%20the%20evening%20of%20the%20treatment%20session%20and%20attended%20a%20debriefing%20the%20next%20morning.%20The%20session%20was%20repeated%20a%20month%20later%20and%20again%20a%20month%20after%20that.%20In%20between%2C%20patients%20had%20telephone%20contact%20with%20the%20raters%2C%20who%20were%20blinded%20to%20the%20treatment%20received.%20%20Follow-up%20assessments%20were%20conducted%202%20months%20after%20the%20third%20treatment%20session%20and%20again%20at%2012%20months.%20The%20primary%20outcome%20measure%20was%20change%20in%20Clinician%20Administered%20PTSD%20Scale%20for%20DSM%205%20%28CAPS-5%29%20score%20from%20baseline.%5Cn%5Cn%26quot%3BDramatic%20Improvement%26quot%3B%20Results%20showed%20that%20both%20the%20MDMA%20and%20placebo%20groups%20experienced%20a%20statistically%20significant%20improvement%20in%20PTSD%20symptoms%2C%20%26quot%3Bbut%20MDMA%20had%20a%20dramatically%20significant%20improvement%2C%20with%20an%20effect%20size%20of%20over%200.9%2C%26quot%3B%20Kolk%20said.%20%20The%20MDMA%20group%20also%20reported%20enhanced%20mood%20and%20well-being%2C%20increased%20responsiveness%20to%20emotional%20and%20sensory%20stimuli%2C%20a%20greater%20sense%20of%20closeness%20to%20other%20people%2C%20and%20a%20greater%20feeling%20of%20empathy.%20%20Patients%20also%20reported%20having%20heightened%20openness%2C%20%26quot%3Band%20clearly%20the%20issue%20of%20empathy%20for%20themselves%20and%20others%20was%20a%20very%20large%20part%20of%20the%20process%2C%26quot%3B%20said%20Kolk.%20%20%26quot%3BBut%20for%20me%2C%20the%20most%20interesting%20part%20of%20the%20study%20is%20that%20the%20Adverse%20Childhood%20Experiences%20scale%20had%20no%20effect%2C%26quot%3B%20he%20noted.%20In%20other%20words%2C%20%26quot%3Bthe%20amount%20of%20childhood%20adverse%20experiences%20did%20not%20predict%20outcomes%2C%20which%20was%20very%20surprising%20because%20usually%20those%20patients%20are%20very%20treatment%20resistant.%26quot%3B%20%20Kolk%20added%20that%20the%20the%20dissociative%20subtype%20of%20PTSD%20was%20first%20described%20in%20DSM-5%20and%20that%20patients%20are%20%26quot%3Bnotoriously%20unresponsive%20to%20most%20unconventional%20treatments.%26quot%3B%20%20In%20the%20current%20study%2C%2013%20patients%20met%20the%20criteria%20for%20the%20subtype%2C%20and%20investigators%20found%20they%20%26quot%3Bdid%20better%20than%20people%20with%20classical%20PTSD%2C%26quot%3B%20Kolk%20said.%20He%20added%20that%20this%20is%20a%20%26quot%3Bvery%2C%20very%20important%20finding.%26quot%3B%5Cn%5CnCarefully%20Controlled%20In%20a%20pooled%20phase%202%20data%20analysis%2C%2082%25%20of%20patients%20reported%20a%20significant%20improvement%20by%20the%20end%20of%20treatment%3B%2056%25%20reported%20that%20they%20no%20longer%20had%20PTSD.%20%20In%20addition%2C%2067%25%20of%20patients%20no%20longer%20met%20diagnostic%20criteria%20for%20PTSD.%20These%20included%20patients%20who%20had%20crossed%20over%20to%20active%20treatment%20from%20the%20placebo%20group.%20%20Eleven%20patients%20%2812%25%29%20experienced%20relapse%20by%2012%20months%3B%20in%20nine%20of%20the%20cases%2C%20this%20was%20due%20to%20the%20presence%20of%20additional%20stressors.%20%20Overall%2C%20there%20were%20%26quot%3Bvery%20few%20adverse%20side%20effects%2C%26quot%3B%20Kolk%20noted.%20In%20addition%2C%20%26quot%3Bthere%20were%20really%20no%20serious%20mental%20side%20effects%2C%26quot%3B%20despite%20the%20patients%26%23039%3B%20%26quot%3Bopening%20up%20so%20much%20very%20painful%20material%2C%26quot%3B%20he%20added.%20%20The%20most%20common%20adverse%20events%20among%20the%20MDMA%20group%20were%20muscle%20tightness%20%2863%25%29%2C%20decreased%20appetite%20%2852%25%29%2C%20nausea%20%2830%25%29%2C%20hyperhidrosis%20%2820%25%29%2C%20and%20feeling%20cold%20%2820%25%29.%20These%20effects%20were%20%26quot%3Bquite%20small%20%5Band%5D%20the%20sort%20of%20side%20effects%20you%20would%20expect%20in%20response%20to%20an%20amphetamine%20substance%20like%20MDMA%2C%26quot%3B%20said%20Kolk.%20%20%26quot%3BAn%20important%20reason%20why%20we%20think%20the%20side%20effect%20profile%20is%20so%20good%20is%20because%20the%20study%20was%20extremely%20carefully%20done%2C%20very%20carefully%20controlled%2C%26quot%3B%20he%20added.%20%26quot%3BThere%20was%20a%20great%20deal%20of%20support%2C%20%5Band%5D%20we%20paid%20an%20enormous%20amount%20of%20attention%20to%20creating%20a%20very%20safe%20context%20in%20which%20this%20drug%20was%20being%20used.%26quot%3B%20%20However%2C%20he%20expressed%20concern%20that%20%26quot%3Bas%20people%20see%20the%20very%20good%20results%2C%20they%20may%20skimp%20a%20little%20bit%20on%20the%20creation%20of%20the%20context%20and%20not%20have%20as%20careful%20a%20psychotherapy%20protocol%20as%20we%20had%20here.%26quot%3B%5Cn%5Cn%26quot%3BOn%20the%20Right%20Track%26quot%3B%20Commenting%20on%20the%20findings%20for%20Medscape%20Medical%20News%2C%20David%20Nutt%2C%20MD%2C%20PhD%2C%20Edmond%20J.%20Safra%20Professor%20of%20Neuropsychopharmacology%2C%20Imperial%20College%20London%2C%20United%20Kingdom%2C%20said%20the%20results%20are%20proof%20that%20the%20investigators%26%23039%3B%20%26quot%3Bearlier%20smaller%20trials%20of%20MDMA%20were%20on%20the%20right%20track.%20%20%26quot%3BThis%20larger%20and%20multicenter%20trial%20shows%20that%20MDMA%20therapy%20can%20be%20broadened%20into%20newer%20research%20groups%2C%20which%20augurs%20well%20for%20the%20much%20larger%20rollout%20that%20will%20be%20required%20once%20it%20gets%20a%20license%2C%26quot%3B%20said%20Nutt%2C%20who%20was%20not%20involved%20with%20the%20research.%20%20He%20added%2C%20%26quot%3Bthe%20prior%20evidence%20of%20the%20safety%20of%20MDMA%20has%20%5Bnow%5D%20been%20confirmed.%26quot%3B%20The%20study%20represents%20an%20%26quot%3Bimportant%20step%20in%20the%20path%20to%20the%20clinical%20use%20of%20MDMA%20for%20PTSD%2C%26quot%3B%20Nutt%20said.%22%2C%22date%22%3A%222021%20April%2014%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.medscape.com%5C%2Fviewarticle%5C%2F949243%3Fsrc%3DWNL_mdpls_210416_mscpedit_psych%26uac%3D25072MJ%26spon%3D12%26impID%3D3315763%26faf%3D1%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22GIUQQS3W%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kamboj%20et%20al.%22%2C%22parsedDate%22%3A%222018-08%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKamboj%2C%20S.%20K.%2C%20Walld%26%23xE9%3Bn%2C%20Y.%20S.%20E.%2C%20Falconer%2C%20C.%20J.%2C%20Alotaibi%2C%20M.%20R.%2C%20Blagbrough%2C%20I.%20S.%2C%20Husbands%2C%20S.%20M.%2C%20%26amp%3B%20Freeman%2C%20T.%20P.%20%282018%29.%20Additive%20effects%20of%203%2C4-Methylenedioxymethamphetamine%20%28MDMA%29%20and%20compassionate%20imagery%20on%20self-compassion%20in%20recreational%20users%20of%20ecstasy.%20%26lt%3Bi%26gt%3BMindfulness%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B9%26lt%3B%5C%2Fi%26gt%3B%284%29%2C%201134%26%23x2013%3B1145.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs12671-017-0849-0%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs12671-017-0849-0%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Additive%20effects%20of%203%2C4-Methylenedioxymethamphetamine%20%28MDMA%29%20and%20compassionate%20imagery%20on%20self-compassion%20in%20recreational%20users%20of%20ecstasy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sunjeev%20K.%22%2C%22lastName%22%3A%22Kamboj%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ylva%20S.%20E.%22%2C%22lastName%22%3A%22Walld%5Cu00e9n%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%20J.%22%2C%22lastName%22%3A%22Falconer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Majdah%20Raji%22%2C%22lastName%22%3A%22Alotaibi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ian%20S.%22%2C%22lastName%22%3A%22Blagbrough%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20M.%22%2C%22lastName%22%3A%22Husbands%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tom%20P.%22%2C%22lastName%22%3A%22Freeman%22%7D%5D%2C%22abstractNote%22%3A%22%28Available%20in%20free%20full%20text%29%203%2C4-Methylenedioxymethylamphetamine%20%28MDMA%3B%5Cu2018ecstasy%5Cu2019%29%20produces%20prosocial%20subjective%20effects%20that%20may%20extend%20to%20affiliative%20feelings%20towards%20the%20self.%20Behavioural%20techniques%20can%20produce%20similar%20self-directed%20affiliation.%20For%20example%2C%20compassionate%20imagery%20%28CI%29%20and%20ecstasy%20reduce%20self-criticism%20and%20increase%20self-compassion%20to%20a%20similar%20extent%2C%20with%20the%20effects%20of%20CI%20enhanced%20in%20the%20presence%20of%20ecstasy.%20Here%2C%20we%20examine%20self-compassion%20and%20self-criticism%20in%20recreational%20users%20who%20consumed%20chemically%20verified%20MDMA%20in%20a%20within-subjects%20crossover%20study.%20In%20a%20naturalistic%20setting%2C%20polydrug-using%20participants%20performed%20a%20self-focused%20CI%20exercise%20on%20two%20occasions%20separated%20by%20%5Cu22656%5Cu00a0days%3A%20once%20having%20consumed%20self-sourced%20MDMA%20and%20once%20not.%20Effects%20on%20state%20self-criticism%2C%20self-compassion%20and%20emotional%20empathy%20were%20assessed%20before%20and%20after%20MDMA%20use%20%28or%20over%20an%20extended%20baseline%20period%20on%20the%20occasion%20that%20MDMA%20was%20not%20consumed%29%20and%20reassessed%20after%20CI.%20In%20participants%20%28n%5Cu00a0%3D%5Cu00a020%3B%208%20women%29%20whose%20ecstasy%20contained%20MDMA%20and%20no%20other%20drug%2C%20CI%20and%20MDMA%20appeared%20to%20separately%20increase%20emotional%20empathy%20%28to%20critical%20facial%20expressions%29%20and%20self-compassion.%20The%20effects%20of%20CI%20and%20MDMA%20on%20self-compassion%20also%20appeared%20to%20be%20additive.%20Establishing%20the%20observed%20effects%20in%20controlled%20studies%20will%20be%20critical%20for%20determining%20the%20combined%20utility%20of%20these%20approaches%20in%20fostering%20adaptive%20self-attitudes%20in%20a%20therapeutic%20context.%22%2C%22date%22%3A%222018%20August%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1007%5C%2Fs12671-017-0849-0%22%2C%22ISSN%22%3A%221868-8535%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs12671-017-0849-0%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22AHFD99VZ%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Austin%20et%20al.%22%2C%22parsedDate%22%3A%222019-03-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAustin%2C%20E.%2C%20Myron%2C%20H.%20S.%2C%20Summerbell%2C%20R.%20K.%2C%20%26amp%3B%20Mackenzie%2C%20C.%20A.%20%282019%29.%20Acute%20renal%20injury%20cause%20by%20confirmed%20Psilocybe%20cubensis%20mushroom%20ingestion.%20%26lt%3Bi%26gt%3BMedical%20Mycology%20Case%20Reports%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B23%26lt%3B%5C%2Fi%26gt%3B%2C%2055%26%23x2013%3B57.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.mmcr.2018.12.007%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.mmcr.2018.12.007%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Acute%20renal%20injury%20cause%20by%20confirmed%20Psilocybe%20cubensis%20mushroom%20ingestion%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%22%2C%22lastName%22%3A%22Austin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hilary%20S.%22%2C%22lastName%22%3A%22Myron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20K.%22%2C%22lastName%22%3A%22Summerbell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constance%20A.%22%2C%22lastName%22%3A%22Mackenzie%22%7D%5D%2C%22abstractNote%22%3A%22%28Available%20in%20free%20full%20text%29%20Psilocybe%20mushrooms%20are%20consumed%20for%20their%20hallucinogenic%20properties.%20Fortunately%2C%20there%20are%20relatively%20few%20adverse%20effects%20associated%20with%20their%20consumption.%20This%20is%20the%20first%20reported%20case%20of%20acute%20kidney%20injury%20%28AKI%29%20secondary%20to%20confirmed%20ingestion%20of%20Psilocybe%20cubensis%20mushroom.%20A%2015-year-old%20male%20developed%20symptomatic%20AKI%2036%5Cu202fh%20post-ingestion%20of%20Psilocybe%20cubensis%20mushrooms.%20He%20was%20admitted%20to%20hospital%20with%20hypertension%2C%20nausea%20and%20abdominal%20pain%20and%20a%20creatinine%20of%20450%5Cu202fmmol%5C%2FL.%20A%20sample%20of%20the%20crop%20of%20mushrooms%20was%20confirmed%20by%20mass%20spectrometry%20to%20contain%20psilocin.%20On%20day%205%20post-admission%2C%20he%20was%20discharged%20home.%20Outpatient%20follow-up%20confirmed%20complete%20resolution%20of%20his%20renal%20function.%22%2C%22date%22%3A%22March%201%2C%202019%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.mmcr.2018.12.007%22%2C%22ISSN%22%3A%222211-7539%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS2211753918301490%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%2239R8FQUL%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Harwick%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHarwick%2C%20R.%20M.%2C%20Carlini%2C%20B.%20H.%2C%20%26amp%3B%20Garrett%2C%20S.%20B.%20%282020%29.%20A%20Taxonomy%20of%20Consumers%26%23x2019%3B%20Perspectives%20on%20the%20Function%20of%20Cannabis%20in%20Their%20Lives%3A%20A%20Qualitative%20Study%20in%20WA%20State%2C%20USA.%20%26lt%3Bi%26gt%3BJournal%20of%20Psychoactive%20Drugs%26lt%3B%5C%2Fi%26gt%3B%2C%201%26%23x2013%3B8.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F02791072.2020.1763522%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F02791072.2020.1763522%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20Taxonomy%20of%20Consumers%5Cu2019%20Perspectives%20on%20the%20Function%20of%20Cannabis%20in%20Their%20Lives%3A%20A%20Qualitative%20Study%20in%20WA%20State%2C%20USA%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robin%20M.%22%2C%22lastName%22%3A%22Harwick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%20H.%22%2C%22lastName%22%3A%22Carlini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sharon%20B.%22%2C%22lastName%22%3A%22Garrett%22%7D%5D%2C%22abstractNote%22%3A%22ABSTRACT%20US%20state-level%20policy%20often%20divides%20legal%20cannabis%20use%20into%20medical%20and%20recreational%20categories.%20However%2C%20research%20suggests%5Cu00a0medical%20and%20non-medical%5Cu00a0cannabis%20consumption%20often%20overlaps%20and%20consumers%26%23039%3B%20relationship%20with%20cannabis%20may%20change.%20This%20study%20aimed%20to%20understand%20cannabis%20consumption%20from%20the%20perspective%20of%20consumers.%20Focus%20group%20participants%20shared%20their%20perspectives%20on%20motivations%2C%20settings%2C%20and%20contexts%20for%20consumption.%20A%20three-category%20taxonomy%20of%20cannabis%20consumption%20emerged%20from%20the%20data%20%3F%20Casual%2C%20intentional%2C%20and%20therapeutic.%20Within%20each%20category%2C%20there%20is%20potential%20for%20high-%20and%20low-risk%20behaviors.%20In%20the%20casual%20group%2C%20participants%20rarely%20purchased%20cannabis%20and%20only%20partook%20if%20it%20was%20freely%20available.%20Participants%20in%20the%20intentional%20group%20were%20knowledgeable%20about%20the%20effects%20produced%20by%20different%20strains%2C%20THC%20levels%2C%20and%20product%20types%2C%20and%20were%20frequently%20self-aware.%20In%20the%20therapeutic%20group%2C%20participants%20consumed%20cannabis%20for%20physical%20or%20mental%20health%20conditions.%20Our%20findings%20suggest%20the%20medical%5C%2Fnon-medical%20dichotomy%20used%20in%20policy%20development%2C%20clinical%20care%2C%20and%20research%20may%20not%20reflect%20how%20regular%20consumers%20perceive%20the%20function%20of%20cannabis%20in%20their%20lives.%20Our%20findings%20suggest%20more%20research%20is%20needed%20to%20identify%20cannabis%3F%20role%20in%20improving%20quality%20of%20life%2C%20when%20it%20increases%20behavioral%20risk%2C%20and%20the%20intersection%20of%20cannabis%20and%20disability.%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1080%5C%2F02791072.2020.1763522%22%2C%22ISSN%22%3A%220279-1072%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F02791072.2020.1763522%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22BTEHMZKK%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ballew%20and%20Omoto%22%2C%22parsedDate%22%3A%222018%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBallew%2C%20M.%2C%20%26amp%3B%20Omoto%2C%20A.%20%282018%29.%20Absorption%3A%20how%20nature%20experiences%20promote%20awe%20and%20other%20positive%20emotions.%20%26lt%3Bi%26gt%3BEcopsychology%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B10%26lt%3B%5C%2Fi%26gt%3B%281%29%2C%2026%26%23x2013%3B35.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1089%5C%2Feco.2017.0044%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1089%5C%2Feco.2017.0044%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Absorption%3A%20how%20nature%20experiences%20promote%20awe%20and%20other%20positive%20emotions%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%22%2C%22lastName%22%3A%22Ballew%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Allen%22%2C%22lastName%22%3A%22Omoto%22%7D%5D%2C%22abstractNote%22%3A%22%28Available%20in%20free%20full%20text%29%20Abstract%20Research%20indicates%20that%20contact%20with%20nature%20elevates%20positive%20emotions%3B%20however%2C%20relatively%20less%20work%20examines%20the%20mechanisms%20responsible%20for%20these%20effects.%20The%20present%20study%20experimentally%20tested%20whether%20a%20brief%20experience%20in%20nature%20promotes%20specific%20positive%20emotions%2C%20such%20as%20happiness%2C%20joy%2C%20and%20feelings%20of%20awe%20because%20of%20feeling%20absorbed%20and%20fully%20involved%20in%20its%20natural%20features.%20Participants%20%28N%5Cu2009%3D%5Cu2009100%29%20were%20randomly%20assigned%20to%20either%20sit%20in%20a%20natural%20environment%20%28i.e.%2C%20a%20local%20arboretum%29%20or%20a%20built%20environment%20%28e.g.%2C%20an%20outdoor%20stadium%29%20for%2015%5Cu2009min%20while%20focusing%20their%20attention%20on%20their%20surroundings%2C%20and%20afterward%20rated%20their%20current%20feelings.%20Results%20from%20structural%20equation%20modeling%20analyses%20indicated%20an%20excellent%20fit%20for%20a%20mediation%20model%20in%20which%20experience%20in%20a%20natural%20environment%2C%20as%20opposed%20to%20a%20built%20setting%2C%20significantly%20enhanced%20feelings%20of%20awe%20and%20other%20positive%20emotions%2C%20%5Cu03c72%20%2822%29%5Cu2009%3D%5Cu200922.86%2C%20p%5Cu2009%3D%5Cu2009.41%2C%20CFI%5Cu2009%3D%5Cu20091.00%2C%20RMSEA%5Cu2009%3D%5Cu2009.02%2C%2090%25%20CI%20%28%26lt%3B.001%2C%20.09%29.%20Moreover%2C%20absorption%20emerged%20as%20a%20significant%20mediator%20of%20nature%26%23039%3Bs%20impact%20on%20positive%20emotions.%20There%20was%20a%20particularly%20strong%20effect%20on%20feelings%20of%20awe%20%2868%25%20of%20variance%20explained%20by%20the%20full%20model%29.%20Results%20indicate%20that%20nature%20fosters%20awe%20and%20other%20positive%20emotions%20when%20people%20feel%20captivated%20and%20engrossed%20in%20their%20surroundings.%20The%20present%20study%20extends%20research%20on%20nature%26%23039%3Bs%20positive%20emotional%20benefits%20and%20provides%20implications%20for%20nature-based%20interventions%2C%20specifically%20on%20the%20significance%20of%20having%20absorbing%20experiences%20in%20nature.%20Key%20Words%3A%20Contact%20with%20nature%5Cu2014Natural%20environment%5Cu2014Positive%20emotions%5Cu2014Awe%5Cu2014Absorption.%22%2C%22date%22%3A%222018%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1089%5C%2Feco.2017.0044%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.liebertpub.com%5C%2Fdoi%5C%2Fabs%5C%2F10.1089%5C%2Feco.2017.0044%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%229H3CHJLI%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Studerus%20et%20al.%22%2C%22parsedDate%22%3A%222011-11%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BStuderus%2C%20E.%2C%20Kometer%2C%20M.%2C%20Hasler%2C%20F.%2C%20%26amp%3B%20Vollenweider%2C%20F.%20X.%20%282011%29.%20Acute%2C%20subacute%20and%20long-term%20subjective%20effects%20of%20psilocybin%20in%20healthy%20humans%3A%20a%20pooled%20analysis%20of%20experimental%20studies.%20%26lt%3Bi%26gt%3BJ%20Psychopharmacol%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B25%26lt%3B%5C%2Fi%26gt%3B%2811%29%2C%201434%26%23x2013%3B1452.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1177%5C%2F0269881110382466%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1177%5C%2F0269881110382466%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Acute%2C%20subacute%20and%20long-term%20subjective%20effects%20of%20psilocybin%20in%20healthy%20humans%3A%20a%20pooled%20analysis%20of%20experimental%20studies%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Studerus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Kometer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Hasler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%20X.%22%2C%22lastName%22%3A%22Vollenweider%22%7D%5D%2C%22abstractNote%22%3A%22Psilocybin%20and%20related%20hallucinogenic%20compounds%20are%20increasingly%20used%20in%20human%20research.%20However%2C%20due%20to%20limited%20information%20about%20potential%20subjective%20side%20effects%2C%20the%20controlled%20medical%20use%20of%20these%20compounds%20has%20remained%20controversial.%20We%20therefore%20analysed%20acute%2C%20short-%20and%20long-term%20subjective%20effects%20of%20psilocybin%20in%20healthy%20humans%20by%20pooling%20raw%20data%20from%20eight%20double-blind%20placebo-controlled%20experimental%20studies%20conducted%20between%201999%20and%202008.%20The%20analysis%20included%20110%20healthy%20subjects%20who%20had%20received%201-4%20oral%20doses%20of%20psilocybin%20%2845-315%20microg%5C%2Fkg%20body%20weight%29.%20Although%20psilocybin%20dose-dependently%20induced%20profound%20changes%20in%20mood%2C%20perception%2C%20thought%20and%20self-experience%2C%20most%20subjects%20described%20the%20experience%20as%20pleasurable%2C%20enriching%20and%20non-threatening.%20Acute%20adverse%20drug%20reactions%2C%20characterized%20by%20strong%20dysphoria%20and%5C%2For%20anxiety%5C%2Fpanic%2C%20occurred%20only%20in%20the%20two%20highest%20dose%20conditions%20in%20a%20relatively%20small%20proportion%20of%20subjects.%20All%20acute%20adverse%20drug%20reactions%20were%20successfully%20managed%20by%20providing%20interpersonal%20support%20and%20did%20not%20need%20psychopharmacological%20intervention.%20Follow-up%20questionnaires%20indicated%20no%20subsequent%20drug%20abuse%2C%20persisting%20perception%20disorders%2C%20prolonged%20psychosis%20or%20other%20long-term%20impairment%20of%20functioning%20in%20any%20of%20our%20subjects.%20The%20results%20suggest%20that%20the%20administration%20of%20moderate%20doses%20of%20psilocybin%20to%20healthy%2C%20high-functioning%20and%20well-prepared%20subjects%20in%20the%20context%20of%20a%20carefully%20monitored%20research%20environment%20is%20associated%20with%20an%20acceptable%20level%20of%20risk.%22%2C%22date%22%3A%222011%20Nov%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1177%5C%2F0269881110382466%22%2C%22ISSN%22%3A%221461-7285%20%28Electronic%29%200269-8811%20%28Linking%29%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F20855349%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22TVI2H25H%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hasler%20et%20al.%22%2C%22parsedDate%22%3A%222004-03%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHasler%2C%20F.%2C%20Grimberg%2C%20U.%2C%20Benz%2C%20M.%20A.%2C%20Huber%2C%20T.%2C%20%26amp%3B%20Vollenweider%2C%20F.%20X.%20%282004%29.%20Acute%20psychological%20and%20physiological%20effects%20of%20psilocybin%20in%20healthy%20humans%3A%20a%20double-blind%2C%20placebo-controlled%20dose%26%23x2013%3Beffect%20study.%20%26lt%3Bi%26gt%3BPsychopharmacology%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B172%26lt%3B%5C%2Fi%26gt%3B%282%29%2C%20145%26%23x2013%3B156.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00213-003-1640-6%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00213-003-1640-6%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Acute%20psychological%20and%20physiological%20effects%20of%20psilocybin%20in%20healthy%20humans%3A%20a%20double-blind%2C%20placebo-controlled%20dose%5Cu2013effect%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Felix%22%2C%22lastName%22%3A%22Hasler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ulrike%22%2C%22lastName%22%3A%22Grimberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marco%20A.%22%2C%22lastName%22%3A%22Benz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Theo%22%2C%22lastName%22%3A%22Huber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Franz%20X.%22%2C%22lastName%22%3A%22Vollenweider%22%7D%5D%2C%22abstractNote%22%3A%22Rationale%20Serotonin%20%285-Hydroxytryptamine%2C%205-HT%29%20receptors%20play%20an%20important%20role%20in%20perception%2C%20affect%20regulation%20and%20attention.%20Pharmacological%20challenge%20with%20the%205-HT2A%20agonist%20psilocybin%20%28PY%29%20is%20useful%20in%20studying%20the%20neurobiological%20basis%20of%20cognition%20and%20consciousness.%20%20Objective%20Investigation%20of%20dose-dependent%20effects%20of%20PY%20on%20psycho%28patho%29logical%20and%20physiological%20parameters.%20%20Methods%20Eight%20subjects%20received%20placebo%20%28PL%29%2C%20and%2045%20%28%5Cu201cvery%20low%20dose%2C%20VLD%5Cu201d%29%2C%20115%20%28%5Cu201clow%20dose%2C%20LD%5Cu201d%29%2C%20215%20%28%5Cu201cmedium%20dose%2C%20MD%5Cu201d%29%2C%20and%20315%20%28%5Cu201chigh%20dose%2C%20HD%5Cu201d%29%20%5Cu03bcg%5C%2Fkg%20body%20weight%20PY.%20%5BFor%20a%2070kg%20person%2C%20this%20is%20equivalent%20to%20approximately%203%2C%208%2C%2015%20and%2022mg%20doses%20of%20psilocybin%5D.%20The%20%5Cu201cAltered%20States%20of%20Consciousness%20Rating%20Scale%5Cu201d%20%285D-ASC%29%2C%20the%20%5Cu201cFrankfurt%20Attention%20Inventory%5Cu201d%20%28FAIR%29%2C%20and%20the%20%5Cu201cAdjective%20Mood%20Rating%20Scale%5Cu201d%20%28AMRS%29%20were%20used%20to%20assess%20the%20effects%20of%20PY%20on%20psycho%28patho%29logical%20core%20dimensions%2C%20attention%2C%20and%20mood.%20A%2024-h%20electrocardiogram%20%28EKG%29%20was%20recorded%20and%20blood%20pressure%20was%20measured.%20Plasma%20concentrations%20of%20thyroid-stimulating%20hormone%20%28TSH%29%2C%20prolactin%20%28PRL%29%2C%20cortisol%20%28CORT%29%2C%20adrenocorticotropic%20hormone%20%28ACTH%29%2C%20and%20standard%20clinical%20chemical%20parameters%20were%20determined.%20%20Results%20PY%20dose%20dependently%20increased%20scores%20of%20all%205D-ASC%20core%20dimensions.%20Only%20one%20subject%20reacted%20with%20transient%20anxiety%20to%20HD%20PY.%20Compared%20with%20PL%2C%20MD%20and%20HD%20PY%20led%20to%20a%2050%25%20reduction%20of%20performance%20in%20the%20FAIR%20test.%20%5Cu201cGeneral%20inactivation%5Cu201d%2C%20%5Cu201cemotional%20excitability%5Cu201d%2C%20and%20%5Cu201cdreaminess%5Cu201d%20were%20the%20only%20domains%20of%20the%20AMRS%20showing%20increased%20scores%20following%20MD%20and%20HD%20PY.%20The%20mean%20arterial%20blood%20pressure%20%28MAP%29%20was%20moderately%20elevated%20only%2060%20min%20following%20administration%20of%20HD%20PY.%20Neither%20EKG%20nor%20body%20temperature%20was%20affected%20by%20any%20dose%20of%20PY.%20TSH%2C%20ACTH%2C%20and%20CORT%20plasma%20levels%20were%20elevated%20during%20peak%20effects%20of%20HD%20PY%2C%20whereas%20PRL%20plasma%20levels%20were%20increased%20following%20MD%20and%20HD%20PY.%20%20Conclusion%20PY%20affects%20core%20dimensions%20of%20altered%20states%20of%20consciousness%20and%20physiological%20parameters%20in%20a%20dose-dependent%20manner.%20Our%20study%20provided%20no%20cause%20for%20concern%20that%20PY%20is%20hazardous%20with%20respect%20to%20somatic%20health.%22%2C%22date%22%3A%222004%20March%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00213-003-1640-6%22%2C%22ISSN%22%3A%221432-2072%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00213-003-1640-6%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%228NA9NL64%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Holze%20et%20al.%22%2C%22parsedDate%22%3A%222020-10-15%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHolze%2C%20F.%2C%20Vizeli%2C%20P.%2C%20Ley%2C%20L.%2C%20M%26%23xFC%3Bller%2C%20F.%2C%20Dolder%2C%20P.%2C%20Stocker%2C%20M.%2C%20Duthaler%2C%20U.%2C%20Varghese%2C%20N.%2C%20Eckert%2C%20A.%2C%20Borgwardt%2C%20S.%2C%20%26amp%3B%20Liechti%2C%20M.%20E.%20%282020%29.%20Acute%20dose-dependent%20effects%20of%20lysergic%20acid%20diethylamide%20in%20a%20double-blind%20placebo-controlled%20study%20in%20healthy%20subjects.%20%26lt%3Bi%26gt%3BNeuropsychopharmacology%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41386-020-00883-6%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41386-020-00883-6%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Acute%20dose-dependent%20effects%20of%20lysergic%20acid%20diethylamide%20in%20a%20double-blind%20placebo-controlled%20study%20in%20healthy%20subjects%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Friederike%22%2C%22lastName%22%3A%22Holze%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%22%2C%22lastName%22%3A%22Vizeli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Ley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Felix%22%2C%22lastName%22%3A%22M%5Cu00fcller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%22%2C%22lastName%22%3A%22Dolder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melanie%22%2C%22lastName%22%3A%22Stocker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Urs%22%2C%22lastName%22%3A%22Duthaler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nimmy%22%2C%22lastName%22%3A%22Varghese%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Eckert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%22%2C%22lastName%22%3A%22Borgwardt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%20E.%22%2C%22lastName%22%3A%22Liechti%22%7D%5D%2C%22abstractNote%22%3A%22%28Available%20in%20free%20full%20text%29%20Growing%20interest%20has%20been%20seen%20in%20using%20lysergic%20acid%20diethylamide%20%28LSD%29%20in%20psychiatric%20research%20and%20therapy.%20However%2C%20no%20modern%20studies%20have%20evaluated%20subjective%20and%20autonomic%20effects%20of%20different%20and%20pharmaceutically%20well-defined%20doses%20of%20LSD.%20We%20used%20a%20double-blind%2C%20randomized%2C%20placebo-controlled%2C%20crossover%20design%20in%2016%20healthy%20subjects%20%28eight%20women%2C%20eight%20men%29%20who%20underwent%20six%2025%5Cu2009h%20sessions%20and%20received%20placebo%2C%20LSD%20%2825%2C%2050%2C%20100%2C%20and%20200%5Cu2009%5Cu00b5g%29%2C%20and%20200%5Cu2009%5Cu00b5g%20LSD%201%5Cu2009h%20after%20administration%20of%20the%20serotonin%205-hydroxytryptamine-2A%20%285-HT2A%29%20receptor%20antagonist%20ketanserin%20%2840%5Cu2009mg%29.%20Test%20days%20were%20separated%20by%20at%20least%2010%20days.%20Outcome%20measures%20included%20self-rating%20scales%20that%20evaluated%20subjective%20effects%2C%20autonomic%20effects%2C%20adverse%20effects%2C%20plasma%20brain-derived%20neurotrophic%20factor%20levels%2C%20and%20pharmacokinetics%20up%20to%2024%5Cu2009h.%20The%20pharmacokinetic-subjective%20response%20relationship%20was%20evaluated.%20LSD%20showed%20dose-proportional%20pharmacokinetics%20and%20first-order%20elimination%20and%20dose-dependently%20induced%20subjective%20responses%20starting%20at%20the%2025%5Cu2009%5Cu00b5g%20dose.%20A%20ceiling%20effect%20was%20observed%20for%20good%20drug%20effects%20at%20100%5Cu2009%5Cu00b5g.%20The%20200%5Cu2009%5Cu00b5g%20dose%20of%20LSD%20induced%20greater%20ego%20dissolution%20than%20the%20100%5Cu2009%5Cu00b5g%20dose%20and%20induced%20significant%20anxiety.%20The%20average%20duration%20of%20subjective%20effects%20increased%20from%206.7%20to%2011%5Cu2009h%20with%20increasing%20doses%20of%2025%5Cu2013200%5Cu2009%5Cu00b5g.%20LSD%20moderately%20increased%20blood%20pressure%20and%20heart%20rate.%20Ketanserin%20effectively%20prevented%20the%20response%20to%20200%5Cu2009%5Cu00b5g%20LSD.%20The%20LSD%20dose%5Cu2013response%20curve%20showed%20a%20ceiling%20effect%20for%20subjective%20good%20effects%2C%20and%20ego%20dissolution%20and%20anxiety%20increased%20further%20at%20a%20dose%20above%20100%5Cu2009%5Cu00b5g.%20These%20results%20may%20assist%20with%20dose%20finding%20for%20future%20LSD%20research.%20The%20full%20psychedelic%20effects%20of%20LSD%20are%20primarily%20mediated%20by%20serotonin%205-HT2A%20receptor%20activation.%22%2C%22date%22%3A%22October%2015%2C%202020%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41386-020-00883-6%22%2C%22ISSN%22%3A%221740-634X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41386-020-00883-6%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22C9QN7PRI%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kim%20et%20al.%22%2C%22parsedDate%22%3A%222020-05-08%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKim%2C%20S.%2C%20Rush%2C%20B.%20S.%2C%20%26amp%3B%20Rice%2C%20T.%20R.%20%282020%29.%20A%20systematic%20review%20of%20therapeutic%20ketamine%20use%20in%20children%20and%20adolescents%20with%20treatment-resistant%20mood%20disorders.%20%26lt%3Bi%26gt%3BEuropean%20Child%20%26amp%3B%20Adolescent%20Psychiatry%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00787-020-01542-3%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00787-020-01542-3%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20systematic%20review%20of%20therapeutic%20ketamine%20use%20in%20children%20and%20adolescents%20with%20treatment-resistant%20mood%20disorders%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susan%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brittany%20S.%22%2C%22lastName%22%3A%22Rush%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Rice%22%7D%5D%2C%22abstractNote%22%3A%22Suicide%20is%20the%20second%20leading%20cause%20of%20death%20in%20the%20United%20States%20among%20individuals%20aged%2010%5Cu201324%2C%20and%20severe%20youth%20depression%20is%20often%20refractory%20to%20the%20current%20standards%20of%20care.%20Many%20studies%20have%20demonstrated%20the%20efficacy%20of%20ketamine%20in%20reducing%20depressive%20symptoms%20in%20adults%20with%20treatment-resistant%20mood%20disorders%2C%20though%20few%20studies%20utilizing%20ketamine%20in%20youth%20populations%20exist.%20This%20systematic%20review%20examines%20the%20current%20state%20of%20evidence%20for%20ketamine%20use%20in%20children%20with%20treatment-resistant%20mood%20disorders.%20We%20conducted%20a%20search%20utilizing%20two%20electronic%20databases%20for%20English-language%20studies%20investigating%20the%20therapeutic%20effects%20and%20side%20effect%20profile%20of%20ketamine%20in%20youth%20%5Cu2264%5Cu200919%5Cu00a0years%20of%20age%20with%20a%20diagnosis%20of%20a%20treatment-resistant%20mood%20disorder.%20Analysis%20included%20subjects%20with%20treatment-resistant%20depression%20with%20and%20without%20psychotic%20features%20and%20with%20bipolar%20disorder.%20Primary%20outcome%20measures%20included%20the%20following%20scales%3A%20Montgomery%5Cu2013Asberg%20Depression%20Rating%20Scale%2C%20Children%5Cu2019s%20Depression%20Rating%20Scale%2C%20Children%5Cu2019s%20Depression%20Rating%20Scale%20Revised%2C%20Child%20Bipolar%20Questionnaire%2C%20Overt%20Aggression%20Scale%2C%20Yale%5Cu2013Brown%20Obsessive%5Cu2013Compulsive%20Scale%2C%20and%20Scale%20for%20Suicidal%20Ideation.%20Four%20published%20studies%20were%20identified%20that%20investigated%20therapeutic%20ketamine%20use%20in%20youth%20for%20the%20primary%20purpose%20of%20treating%20a%20treatment-resistant%20psychiatric%20disorder.%20Three%20additional%20studies%20that%20did%20not%20meet%20eligibility%20criteria%20were%20identified%20and%20discussed.%20Ketamine%20was%20shown%20in%20youth%20to%20generally%20improve%20depressive%20symptoms%2C%20decrease%20acute%20suicidality%2C%20and%20reduce%20mood%20lability%2C%20though%20a%20number%20of%20subjects%20remained%20resistant%20to%20its%20treatment.%20These%20findings%20substantiate%20the%20need%20for%20further%20longitudinal%20studies%20investigating%20ketamine%5Cu2019s%20long-term%20safety%2C%20its%20efficacy%2C%20and%20abuse%20potential%20in%20the%20youth.%22%2C%22date%22%3A%22May%208%2C%202020%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00787-020-01542-3%22%2C%22ISSN%22%3A%221435-165X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00787-020-01542-3%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22D242T6XU%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lifshitz%20et%20al.%22%2C%22parsedDate%22%3A%222019-08%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLifshitz%2C%20M.%2C%20van%20Elk%2C%20M.%2C%20%26amp%3B%20Luhrmann%2C%20T.%20M.%20%282019%29.%20Absorption%20and%20spiritual%20experience%3A%20A%20review%20of%20evidence%20and%20potential%20mechanisms.%20%26lt%3Bi%26gt%3BConsciousness%20and%20Cognition%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B73%26lt%3B%5C%2Fi%26gt%3B%2C%20102760.%20PubMed.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.concog.2019.05.008%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.concog.2019.05.008%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Absorption%20and%20spiritual%20experience%3A%20A%20review%20of%20evidence%20and%20potential%20mechanisms%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Lifshitz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michiel%22%2C%22lastName%22%3A%22van%20Elk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%20M.%22%2C%22lastName%22%3A%22Luhrmann%22%7D%5D%2C%22abstractNote%22%3A%22Some%20people%20seem%20to%20have%20a%20%5Cu2018talent%5Cu2019%20for%20spiritual%20experience%3A%20they%20readily%20sense%20the%20presence%20of%20supernatural%20beings%2C%20receive%20special%20messages%20from%20God%2C%20and%20report%20intense%20feelings%20of%20self-transcendence%2C%20awe%20and%20wonder.%20Here%20we%20review%20converging%20strands%20of%20evidence%20to%20argue%20that%20the%20trait%20of%20%26%23039%3Babsorption%26%23039%3B%20captures%20a%20general%20proclivity%20for%20having%20spiritual%20experiences.%20Participants%20scoring%20highly%20on%20the%20Tellegen%20Absorption%20Scale%20report%20vivid%20experiences%20of%20hearing%20God%26%23039%3Bs%20voice%20during%20prayer%2C%20intense%20mystical%20experiences%20in%20response%20to%20psychedelics%20or%20placebo%20brain-stimulation%2C%20and%20strong%20feelings%20of%20presence%20and%20transcendence%20when%20confronted%20with%20natural%20beauty%2C%20virtual%20reality%2C%20or%20music.%20Several%20mechanisms%20may%20help%20to%20explain%20the%20relationship%20between%20absorption%20and%20spiritual%20experience.%20We%20suggest%20that%20absorption%20captures%20an%20experiential%20mindset%20that%20intensifies%20inner%20and%20outer%20sensory%20experience%20in%20ways%20that%20reflect%20both%20prior%20expectation%20and%20novel%20sensory%20engagement.%20It%20seems%20to%20enable%20that%20which%20must%20be%20imagined%20to%20feel%20more%20real.%22%2C%22date%22%3A%22August%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.concog.2019.05.008%22%2C%22ISSN%22%3A%221053-8100%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1053810018305257%3Fvia%253Dihub%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22EI8QDKYV%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Baggott%20et%20al.%22%2C%22parsedDate%22%3A%222011-03-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBaggott%2C%20M.%20J.%2C%20Coyle%2C%20J.%20R.%2C%20Erowid%2C%20E.%2C%20Erowid%2C%20F.%2C%20%26amp%3B%20Robertson%2C%20L.%20C.%20%282011%29.%20Abnormal%20visual%20experiences%20in%20individuals%20with%20histories%20of%20hallucinogen%20use%3A%20a%20Web-based%20questionnaire.%20%26lt%3Bi%26gt%3BDrug%20Alcohol%20Depend%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B114%26lt%3B%5C%2Fi%26gt%3B%281%29%2C%2061%26%23x2013%3B67.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.drugalcdep.2010.09.006%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.drugalcdep.2010.09.006%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Abnormal%20visual%20experiences%20in%20individuals%20with%20histories%20of%20hallucinogen%20use%3A%20a%20Web-based%20questionnaire%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20J.%22%2C%22lastName%22%3A%22Baggott%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20R.%22%2C%22lastName%22%3A%22Coyle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Erowid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Erowid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20C.%22%2C%22lastName%22%3A%22Robertson%22%7D%5D%2C%22abstractNote%22%3A%22Despite%20longstanding%20reports%20of%20prolonged%20or%20reoccurring%20perceptual%20changes%20in%20a%20subset%20of%20hallucinogen%20users%2C%20very%20little%20is%20known%20about%20Hallucinogen%20Persisting%20Perception%20Disorder%20and%20related%20visual%20abnormalities%20in%20hallucinogen%20users.%20We%20used%20an%20online%20questionnaire%20to%20document%20the%20symptoms%20and%20relationship%20to%20drug%20use%20of%20unusual%20visual%20phenomena%20in%20hallucinogen%20users.%2016%2C192%20individuals%20viewed%20the%20information%20sheet%20and%202679%20were%20included%20in%20the%20study.%20Of%20these%2C%20224%20reported%20having%20unrelated%20diagnoses%20associated%20with%20unusual%20visual%20experiences%20and%20were%20excluded%20from%20main%20analyses.%20Most%20%2860.6%25%29%20of%20the%20remaining%202455%20participants%20reported%20having%20experienced%20drug-free%20visual%20experiences%20that%20resembled%20hallucinogen%20effects.%20Probability%20of%20experiencing%20constant%20or%20near-constant%20symptoms%20was%20predicted%20by%20greater%20past%20exposure%20to%20specific%20hallucinogens%2C%20including%20lysergic%20acid%20diethylamide%20%28LSD%29.%20Although%20symptoms%20were%20common%2C%20few%20%28104%2C%20or%204.2%25%20of%20the%20sample%29%20found%20them%20distressing%20or%20impairing%20enough%20to%20consider%20seeking%20treatment.%20Visual%20changes%20in%20hallucinogen%20users%20may%20be%20more%20common%20than%20previously%20suspected%20and%20are%20worthy%20of%20further%20study.%22%2C%22date%22%3A%222011%20Mar%201%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.drugalcdep.2010.09.006%22%2C%22ISSN%22%3A%221879-0046%20%28Electronic%29%200376-8716%20%28Linking%29%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F21035275%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22UAJSFWXF%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Madsen%20et%20al.%22%2C%22parsedDate%22%3A%222020-04-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMadsen%2C%20M.%20K.%2C%20Fisher%2C%20P.%20M.%2C%20Stenb%26%23xE6%3Bk%2C%20D.%20S.%2C%20Kristiansen%2C%20S.%2C%20Burmester%2C%20D.%2C%20Lehel%2C%20S.%2C%20P%26%23xE1%3Blen%26%23xED%3B%26%23x10D%3Bek%2C%20T.%2C%20Kucha%26%23x159%3B%2C%20M.%2C%20Svarer%2C%20C.%2C%20Ozenne%2C%20B.%2C%20%26amp%3B%20Knudsen%2C%20G.%20M.%20%282020%29.%20A%20single%20psilocybin%20dose%20is%20associated%20with%20long-term%20increased%20mindfulness%2C%20preceded%20by%20a%20proportional%20change%20in%20neocortical%205-HT2A%20receptor%20binding.%20%26lt%3Bi%26gt%3BEuropean%20Neuropsychopharmacology%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B33%26lt%3B%5C%2Fi%26gt%3B%2C%2071%26%23x2013%3B80.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.euroneuro.2020.02.001%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.euroneuro.2020.02.001%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20single%20psilocybin%20dose%20is%20associated%20with%20long-term%20increased%20mindfulness%2C%20preceded%20by%20a%20proportional%20change%20in%20neocortical%205-HT2A%20receptor%20binding%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%20Korsbak%22%2C%22lastName%22%3A%22Madsen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20MacDonald%22%2C%22lastName%22%3A%22Fisher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dea%20Siggaard%22%2C%22lastName%22%3A%22Stenb%5Cu00e6k%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%22%2C%22lastName%22%3A%22Kristiansen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Burmester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Szabolcs%22%2C%22lastName%22%3A%22Lehel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tomas%22%2C%22lastName%22%3A%22P%5Cu00e1len%5Cu00ed%5Cu010dek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%22%2C%22lastName%22%3A%22Kucha%5Cu0159%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claus%22%2C%22lastName%22%3A%22Svarer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brice%22%2C%22lastName%22%3A%22Ozenne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gitte%20M.%22%2C%22lastName%22%3A%22Knudsen%22%7D%5D%2C%22abstractNote%22%3A%22A%20single%20dose%20of%20the%20serotonin%202A%20receptor%20%285-HT2AR%29%20agonist%20psilocybin%20can%20have%20long-lasting%20beneficial%20effects%20on%20mood%2C%20personality%2C%20and%20potentially%20on%20mindfulness%2C%20but%20underlying%20mechanisms%20are%20unknown.%20Here%2C%20we%20for%20the%20first%20time%20conduct%20a%20study%20that%20assesses%20psilocybin%20effects%20on%20cerebral%205-HT2AR%20binding%20with%20%5B11C%5DCimbi-36%20positron%20emission%20tomography%20%28PET%29%20imaging%20and%20on%20personality%20and%20mindfulness.%20Ten%20healthy%20and%20psychedelic-na%5Cu00efve%20volunteers%20underwent%20PET%20neuroimaging%20of%205-HT2AR%20at%20baseline%20%28BL%29%20and%20one%20week%20%281W%29%20after%20a%20single%20oral%20dose%20of%20psilocybin%20%280.2%5Cu20130.3%5Cu00a0mg%5C%2Fkg%29.%20Personality%20%28NEO%20PI-R%29%20and%20mindfulness%20%28MAAS%29%20questionnaires%20were%20completed%20at%20BL%20and%20at%20three-months%20follow-up%20%283M%29.%20Paired%20t-tests%20revealed%20statistically%20significant%20increases%20in%20personality%20Openness%20%28puncorrected%5Cu00a0%3D%5Cu00a00.04%2C%20mean%20change%20%5B95%25CI%5D%3A%204.2%5B0.4%3B%5Cu221e%5D%29%2C%20which%20was%20hypothesized%20a%20priori%20to%20increase%2C%20and%20mindfulness%20%28pFWER%5Cu00a0%3D%5Cu00a00.02%2C%20mean%20change%20%5B95%25CI%5D%3A%200.5%20%5B0.2%3B0.7%5D%29.%20Although%205-HT2AR%20binding%20at%201W%20versus%20BL%20was%20similar%20across%20individuals%20%28puncorrected%5Cu00a0%3D%5Cu00a00.8%2C%20mean%20change%20%5B95%25CI%5D%3A%200.007%20%5B%5Cu22120.04%3B0.06%5D%29%2C%20a%20post%20hoc%20linear%20regression%20analysis%20showed%20that%20change%20in%20mindfulness%20and%205-HT2AR%20correlated%20negatively%20%28%5Cu03b2%20%5B95%25CI%5D%5Cu00a0%3D%5Cu00a0%5Cu22125.0%20%5B%5Cu22129.0%3B%20%5Cu22120.9%5D%2C%20pFWER%3D%200.046%29.%20In%20conclusion%2C%20we%20confirm%20that%20psilocybin%20intake%20is%20associated%20with%20long-term%20increases%20in%20Openness%20and%20%5Cu2013%20as%20a%20novel%20finding%20%5Cu2013%20mindfulness%2C%20which%20may%20be%20a%20key%20element%20of%20psilocybin%20therapy.%20Cerebral%205-HT2AR%20binding%20did%20not%20change%20across%20individuals%20but%20the%20negative%20association%20between%20changes%20in%205-HT2AR%20binding%20and%20mindfulness%20suggests%20that%20individual%20change%20in%205-HT2AR%20levels%20after%20psilocybin%20is%20variable%20and%20represents%20a%20potential%20mechanism%20influencing%20long-term%20effects%20of%20psilocybin%20on%20mindfulness.%22%2C%22date%22%3A%22April%201%2C%202020%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.euroneuro.2020.02.001%22%2C%22ISSN%22%3A%220924-977X%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0924977X20300602%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22G7TLFIM7%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rodr%5Cu0131%5Cu0301guez%20et%20al.%22%2C%22parsedDate%22%3A%222020-04-24%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BRodr%26%23x131%3B%26%23x301%3Bguez%2C%20P.%2C%20Urbanavicius%2C%20J.%2C%20Prieto%2C%20J.%20P.%2C%20Fabius%2C%20S.%2C%20Reyes%2C%20A.%20L.%2C%20Havel%2C%20V.%2C%20Sames%2C%20D.%2C%20Scorza%2C%20C.%2C%20%26amp%3B%20Carrera%2C%20I.%20%282020%29.%20A%20Single%20Administration%20of%20the%20Atypical%20Psychedelic%20Ibogaine%20or%20Its%20Metabolite%20Noribogaine%20Induces%20an%20Antidepressant-Like%20Effect%20in%20Rats.%20%26lt%3Bi%26gt%3BACS%20Chemical%20Neuroscience%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1021%5C%2Facschemneuro.0c00152%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1021%5C%2Facschemneuro.0c00152%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20Single%20Administration%20of%20the%20Atypical%20Psychedelic%20Ibogaine%20or%20Its%20Metabolite%20Noribogaine%20Induces%20an%20Antidepressant-Like%20Effect%20in%20Rats%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paola%22%2C%22lastName%22%3A%22Rodr%5Cu0131%5Cu0301guez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessika%22%2C%22lastName%22%3A%22Urbanavicius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%20Pedro%22%2C%22lastName%22%3A%22Prieto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%22%2C%22lastName%22%3A%22Fabius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%20Laura%22%2C%22lastName%22%3A%22Reyes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vaclav%22%2C%22lastName%22%3A%22Havel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dalibor%22%2C%22lastName%22%3A%22Sames%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cecilia%22%2C%22lastName%22%3A%22Scorza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ignacio%22%2C%22lastName%22%3A%22Carrera%22%7D%5D%2C%22abstractNote%22%3A%22Anecdotal%20reports%20and%20open-label%20case%20studies%20in%20humans%20indicated%20that%20the%20psychedelic%20alkaloid%20ibogaine%20exerts%20profound%20antiaddictive%20effects.%20Ample%20preclinical%20evidence%20demonstrated%20the%20efficacy%20of%20ibogaine%2C%20and%20its%20main%20metabolite%2C%20noribogaine%2C%20in%20substance-use-disorder%20rodent%20models.%20In%20contrast%20to%20addiction%20research%2C%20depression-relevant%20effects%20of%20ibogaine%20or%20noribogaine%20in%20rodents%20have%20not%20been%20previously%20examined.%20We%20have%20recently%20reported%20that%20the%20acute%20ibogaine%20administration%20induced%20a%20long-term%20increase%20of%20brain-derived%20neurotrophic%20factor%20mRNA%20levels%20in%20the%20rat%20prefrontal%20cortex%2C%20which%20led%20us%20to%20hypothesize%20that%20ibogaine%20may%20elicit%20antidepressant-like%20effects%20in%20rats.%20Accordingly%2C%20we%20characterized%20behavioral%20effects%20%28dose-%20and%20time-dependence%29%20induced%20by%20the%20acute%20ibogaine%20and%20noribogaine%20administration%20in%20rats%20using%20the%20forced%20swim%20test%20%28FST%2C%2020%20and%2040%20mg%5C%2Fkg%20i.p.%2C%20single%20injection%20for%20each%20dose%29.%20We%20also%20examined%20the%20correlation%20between%20plasma%20and%20brain%20concentrations%20of%20ibogaine%20and%20noribogaine%20and%20the%20elicited%20behavioral%20response.%20We%20found%20that%20ibogaine%20and%20noribogaine%20induced%20a%20dose-%20and%20time-dependent%20antidepressant-like%20effect%20without%20significant%20changes%20of%20animal%20locomotor%20activity.%20Noribogaine%5Cu2019s%20FST%20effect%20was%20short-lived%20%2830%20min%29%20and%20correlated%20with%20high%20brain%20concentrations%20%28estimated%20%26gt%3B8%20%5Cu03bcM%20of%20free%20drug%29%2C%20while%20the%20ibogaine%5Cu2019s%20antidepressant-like%20effect%20was%20significant%20at%203%20h.%20At%20this%20time%20point%2C%20both%20ibogaine%20and%20noribogaine%20were%20present%20in%20rat%20brain%20at%20concentrations%20that%20cannot%20produce%20the%20same%20behavioral%20outcome%20on%20their%20own%20%28ibogaine%20%5Cu223c0.5%20%5Cu03bcM%2C%20noribogaine%20%5Cu223c2.5%20%5Cu03bcM%29.%20Our%20data%20suggests%20a%20polypharmacological%20mechanism%20underpinning%20the%20antidepressant-like%20effects%20of%20ibogaine%20and%20noribogaine.%22%2C%22date%22%3A%22April%2024%2C%202020%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1021%5C%2Facschemneuro.0c00152%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1021%5C%2Facschemneuro.0c00152%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22EHM39U2G%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pribish%20et%20al.%22%2C%22parsedDate%22%3A%222020-04-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BPribish%2C%20A.%2C%20Wood%2C%20N.%2C%20%26amp%3B%20Kalava%2C%20A.%20%282020%29.%20A%20review%20of%20nonanesthetic%20uses%20of%20ketamine.%20%26lt%3Bi%26gt%3BAnesthesiology%20Research%20and%20Practice%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B2020%26lt%3B%5C%2Fi%26gt%3B%2C%205798285.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1155%5C%2F2020%5C%2F5798285%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1155%5C%2F2020%5C%2F5798285%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20review%20of%20nonanesthetic%20uses%20of%20ketamine%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abby%22%2C%22lastName%22%3A%22Pribish%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%22%2C%22lastName%22%3A%22Wood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arun%22%2C%22lastName%22%3A%22Kalava%22%7D%5D%2C%22abstractNote%22%3A%22%28Available%20in%20free%20full%20text%29%20Ketamine%2C%20a%20nonselective%20NMDA%20receptor%20antagonist%2C%20is%20used%20widely%20in%20medicine%20as%20an%20anesthetic%20agent.%20However%2C%20ketamine%5Cu2019s%20mechanisms%20of%20action%20lead%20to%20widespread%20physiological%20effects%2C%20some%20of%20which%20are%20now%20coming%20to%20the%20forefront%20of%20research%20for%20the%20treatment%20of%20diverse%20medical%20disorders.%20This%20paper%20aims%20at%20reviewing%20recent%20data%20on%20key%20nonanesthetic%20uses%20of%20ketamine%20in%20the%20current%20literature.%20MEDLINE%2C%20CINAHL%2C%20and%20Google%20Scholar%20databases%20were%20queried%20to%20find%20articles%20related%20to%20ketamine%20in%20the%20treatment%20of%20depression%2C%20pain%20syndromes%20including%20acute%20pain%2C%20chronic%20pain%2C%20and%20headache%2C%20neurologic%20applications%20including%20neuroprotection%20and%20seizures%2C%20and%20alcohol%20and%20substance%20use%20disorders.%20It%20can%20be%20concluded%20that%20ketamine%20has%20a%20potential%20role%20in%20the%20treatment%20of%20all%20of%20these%20conditions.%20However%2C%20research%20in%20this%20area%20is%20still%20in%20its%20early%20stages%2C%20and%20larger%20studies%20are%20required%20to%20evaluate%20ketamine%5Cu2019s%20efficacy%20for%20nonanesthetic%20purposes%20in%20the%20general%20population.%22%2C%22date%22%3A%22April%201%2C%202020%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1155%5C%2F2020%5C%2F5798285%22%2C%22ISSN%22%3A%221687-6962%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1155%5C%2F2020%5C%2F5798285%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22UDPYZ9VV%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Halpern%20et%20al.%22%2C%22parsedDate%22%3A%222018%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHalpern%2C%20J.%20H.%2C%20Lerner%2C%20A.%20G.%2C%20%26amp%3B%20Passie%2C%20T.%20%282018%29.%20A%20Review%20of%20Hallucinogen%20Persisting%20Perception%20Disorder%20%28HPPD%29%20and%20an%20Exploratory%20Study%20of%20Subjects%20Claiming%20Symptoms%20of%20HPPD.%20%26lt%3Bi%26gt%3BCurr%20Top%20Behav%20Neurosci%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B36%26lt%3B%5C%2Fi%26gt%3B%2C%20333%26%23x2013%3B360.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2F7854_2016_457%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2F7854_2016_457%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20Review%20of%20Hallucinogen%20Persisting%20Perception%20Disorder%20%28HPPD%29%20and%20an%20Exploratory%20Study%20of%20Subjects%20Claiming%20Symptoms%20of%20HPPD%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20H.%22%2C%22lastName%22%3A%22Halpern%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20G.%22%2C%22lastName%22%3A%22Lerner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%22%2C%22lastName%22%3A%22Passie%22%7D%5D%2C%22abstractNote%22%3A%22Hallucinogen%20persisting%20perception%20disorder%20%28HPPD%29%20is%20rarely%20encountered%20in%20clinical%20settings.%20It%20is%20described%20as%20a%20re-experiencing%20of%20some%20perceptual%20distortions%20induced%20while%20intoxicated%20and%20suggested%20to%20subsequently%20cause%20functional%20impairment%20or%20anxiety.%20Two%20forms%20exist%3A%20Type%201%2C%20which%20are%20brief%20%26quot%3Bflashbacks%2C%26quot%3B%20and%20Type%202%20claimed%20to%20be%20chronic%2C%20waxing%2C%20and%20waning%20over%20months%20to%20years.%20A%20review%20of%20HPPD%20is%20presented.%20In%20addition%2C%20data%20from%20a%20comprehensive%20survey%20of%2020%20subjects%20reporting%20Type-2%20HPPD-like%20symptoms%20are%20presented%20and%20evaluated.%20Dissociative%20Symptoms%20are%20consistently%20associated%20with%20HPPD.%20Results%20of%20the%20survey%20suggest%20that%20HPPD%20is%20in%20most%20cases%20due%20to%20a%20subtle%20over-activation%20of%20predominantly%20neural%20visual%20pathways%20that%20worsens%20anxiety%20after%20ingestion%20of%20arousal-altering%20drugs%2C%20including%20non-hallucinogenic%20substances.%20Individual%20or%20family%20histories%20of%20anxiety%20and%20pre-drug%20use%20complaints%20of%20tinnitus%2C%20eye%20floaters%2C%20and%20concentration%20problems%20may%20predict%20vulnerability%20for%20HPPD.%20Future%20research%20should%20take%20a%20broader%20outlook%20as%20many%20perceptual%20symptoms%20reported%20were%20not%20first%20experienced%20while%20intoxicated%20and%20are%20partially%20associated%20with%20pre-existing%20psychiatric%20comorbidity.%22%2C%22date%22%3A%222018%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1007%5C%2F7854_2016_457%22%2C%22ISSN%22%3A%221866-3370%20%28Print%29%201866-3370%20%28Linking%29%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F27822679%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22H4C38CGY%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Dakwar%20et%20al.%22%2C%22parsedDate%22%3A%222018-11-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BDakwar%2C%20E.%2C%20Nunes%2C%20E.%20V.%2C%20Hart%2C%20C.%20L.%2C%20Hu%2C%20M.%20C.%2C%20Foltin%2C%20R.%20W.%2C%20%26amp%3B%20Levin%2C%20F.%20R.%20%282018%29.%20A%20sub-set%20of%20psychoactive%20effects%20may%20be%20critical%20to%20the%20behavioral%20impact%20of%20ketamine%20on%20cocaine%20use%20disorder%3A%20Results%20from%20a%20randomized%2C%20controlled%20laboratory%20study.%20%26lt%3Bi%26gt%3BNeuropharmacology%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B142%26lt%3B%5C%2Fi%26gt%3B%2C%20270%26%23x2013%3B276.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.neuropharm.2018.01.005%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.neuropharm.2018.01.005%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20sub-set%20of%20psychoactive%20effects%20may%20be%20critical%20to%20the%20behavioral%20impact%20of%20ketamine%20on%20cocaine%20use%20disorder%3A%20Results%20from%20a%20randomized%2C%20controlled%20laboratory%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Dakwar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20V.%22%2C%22lastName%22%3A%22Nunes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20L.%22%2C%22lastName%22%3A%22Hart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20C.%22%2C%22lastName%22%3A%22Hu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20W.%22%2C%22lastName%22%3A%22Foltin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%20R.%22%2C%22lastName%22%3A%22Levin%22%7D%5D%2C%22abstractNote%22%3A%22Abstracts%20Efforts%20to%20translate%20sub-anesthetic%20ketamine%20infusions%20into%20widespread%20clinical%20use%20have%20centered%20around%20developing%20medications%20with%20comparable%20neurobiological%20activity%2C%20but%20with%20attenuated%20psychoactive%20effects%20so%20as%20to%20minimize%20the%20risk%20of%20behavioral%20toxicity%20and%20abuse%20liability.%20Converging%20lines%20of%20research%2C%20however%2C%20suggest%20that%20some%20of%20the%20psychoactive%20effects%20of%20sub-anesthetic%20ketamine%20may%20have%20therapeutic%20potential.%20Here%2C%20we%20assess%20whether%20a%20subset%20of%20these%20effects%20%5Cu2013%20the%20so-called%20mystical-type%20experience%20%5Cu2013%20mediates%20the%20effect%20of%20ketamine%20on%20craving%20and%20cocaine%20use%20in%20cocaine%20dependent%20research%20volunteers.%20We%20found%20that%20ketamine%20leads%20to%20significantly%20greater%20acute%20mystical-type%20effects%20%28by%20Hood%20Mysticism%20Scale%3A%20HMS%29%2C%20dissociation%20%28by%20Clinician%20Administered%20Dissociative%20States%20Scale%3A%20CADSS%29%2C%20and%20near-death%20experience%20phenomena%20%28by%20the%20Near-Death%20Experience%20Scale%3A%20NDES%29%2C%20relative%20to%20the%20active%20control%20midazolam.%20HMS%20score%2C%20but%20not%20the%20CADSS%20or%20NDES%20score%2C%20was%20found%20to%20mediate%20the%20effect%20of%20ketamine%20on%20global%20improvement%20%28decreased%20cocaine%20use%20and%20craving%29%20over%20the%20post-infusion%20period.%20This%20is%20the%20first%20controlled%20study%20to%20show%20that%20mystical-type%20phenomena%2C%20long%20considered%20to%20have%20therapeutic%20potential%2C%20may%20work%20to%20impact%20decision-making%20and%20behavior%20in%20a%20sustained%20manner.%20These%20data%20suggest%20that%20an%20important%20direction%20for%20medication%20development%20is%20the%20identification%20of%20ketamine-like%20pharmacotherapy%20that%20is%20selectively%20psychoactive%20%28as%20opposed%20to%20free%20of%20experiential%20effects%20entirely%29%2C%20so%20that%20mystical-type%20perspectival%20shifts%20are%20more%20reliably%20produced%20and%20factors%20lending%20to%20abuse%20or%20behavioral%20impairment%20are%20minimized.%20Future%20research%20can%20further%20clarify%20the%20relationship%20between%20medication-occasioned%20mystical-type%20effects%20and%20clinical%20benefit%20for%20different%20disorders.%20This%20article%20is%20part%20of%20the%20Special%20Issue%20entitled%20%5Cu2018Psychedelics%3A%20New%20Doors%2C%20Altered%20Perceptions%5Cu2019.%22%2C%22date%22%3A%22November%201%2C%202018%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.neuropharm.2018.01.005%22%2C%22ISSN%22%3A%220028-3908%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0028390818300054%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22DSUYECNC%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Dakwar%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BDakwar%2C%20E.%2C%20Levin%2C%20F.%2C%20Hart%2C%20C.%20L.%2C%20%26amp%3B%20al.%2C%20%20et.%20%282020%29.%20A%20single%20ketamine%20infusion%20combined%20with%20motivational%20enhancement%20therapy%20for%20alcohol%20use%20disorder%3A%20A%20randomized%20midazolam-controlled%20pilot%20trial.%20%26lt%3Bi%26gt%3BAmerican%20Journal%20of%20Psychiatry%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B177%26lt%3B%5C%2Fi%26gt%3B%282%29%2C%20125%26%23x2013%3B133.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1176%5C%2Fappi.ajp.2019.19070684%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1176%5C%2Fappi.ajp.2019.19070684%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20single%20ketamine%20infusion%20combined%20with%20motivational%20enhancement%20therapy%20for%20alcohol%20use%20disorder%3A%20A%20randomized%20midazolam-controlled%20pilot%20trial%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elias%22%2C%22lastName%22%3A%22Dakwar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frances%22%2C%22lastName%22%3A%22Levin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carl%20L.%22%2C%22lastName%22%3A%22Hart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22et%22%2C%22lastName%22%3A%22al.%22%7D%5D%2C%22abstractNote%22%3A%22Objective%3A%20Pharmacotherapy%20and%20behavioral%20treatments%20for%20alcohol%20use%20disorder%20are%20limited%20in%20their%20effectiveness%2C%20and%20new%20treatments%20with%20innovative%20mechanisms%20would%20be%20valuable.%20In%20this%20pilot%20study%2C%20the%20authors%20tested%20whether%20a%20single%20subanesthetic%20infusion%20of%20ketamine%20administered%20to%20adults%20with%20alcohol%20dependence%20and%20engaged%20in%20motivational%20enhancement%20therapy%20affects%20drinking%20outcomes.%20%20Methods%3A%20Participants%20were%20randomly%20assigned%20to%20a%2052-minute%20intravenous%20administration%20of%20ketamine%20%280.71%20mg%5C%2Fkg%2C%20N%3D17%29%20or%20the%20active%20control%20midazolam%20%280.025%20mg%5C%2Fkg%2C%20N%3D23%29%2C%20provided%20during%20the%20second%20week%20of%20a%205-week%20outpatient%20regimen%20of%20motivational%20enhancement%20therapy.%20Alcohol%20use%20following%20the%20infusion%20was%20assessed%20with%20timeline%20followback%20method%2C%20with%20abstinence%20confirmed%20by%20urine%20ethyl%20glucuronide%20testing.%20A%20longitudinal%20logistic%20mixed-effects%20model%20was%20used%20to%20model%20daily%20abstinence%20from%20alcohol%20over%20the%2021%20days%20after%20ketamine%20infusion.%20%20Results%3A%20Participants%20%28N%3D40%29%20were%20mostly%20middle-aged%20%28mean%20age%3D53%20years%20%5BSD%3D9.8%5D%29%2C%20predominantly%20white%20%2870.3%25%29%2C%20and%20largely%20employed%20%2871.8%25%29%20and%20consumed%20an%20average%20of%20five%20drinks%20per%20day%20prior%20to%20entering%20the%20study.%20Ketamine%20significantly%20increased%20the%20likelihood%20of%20abstinence%2C%20delayed%20the%20time%20to%20relapse%2C%20and%20reduced%20the%20likelihood%20of%20heavy%20drinking%20days%20compared%20with%20midazolam.%20Infusions%20were%20well%20tolerated%2C%20with%20no%20participants%20removed%20from%20the%20study%20as%20a%20result%20of%20adverse%20events.%20%20Conclusions%3A%20A%20single%20ketamine%20infusion%20was%20found%20to%20improve%20measures%20of%20drinking%20in%20persons%20with%20alcohol%20dependence%20engaged%20in%20motivational%20enhancement%20therapy.%20These%20preliminary%20data%20suggest%20new%20directions%20in%20integrated%20pharmacotherapy-behavioral%20treatments%20for%20alcohol%20use%20disorder.%20Further%20research%20is%20needed%20to%20replicate%20these%20promising%20results%20in%20a%20larger%20sample.%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1176%5C%2Fappi.ajp.2019.19070684%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fajp.psychiatryonline.org%5C%2Fdoi%5C%2Fabs%5C%2F10.1176%5C%2Fappi.ajp.2019.19070684%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22RMFD7IKI%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lima%20da%20Cruz%20et%20al.%22%2C%22parsedDate%22%3A%222018-09%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLima%20da%20Cruz%2C%20R.%20V.%2C%20Moulin%2C%20T.%20C.%2C%20Petiz%2C%20L.%20L.%2C%20%26amp%3B%20Le%26%23xE3%3Bo%2C%20R.%20N.%20%282018%29.%20A%20Single%20Dose%20of%205-MeO-DMT%20Stimulates%20Cell%20Proliferation%2C%20Neuronal%20Survivability%2C%20Morphological%20and%20Functional%20Changes%20in%20Adult%20Mice%20Ventral%20Dentate%20Gyrus.%20%26lt%3Bi%26gt%3BFrontiers%20in%20Molecular%20Neuroscience%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B11%26lt%3B%5C%2Fi%26gt%3B%28312%29.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffnmol.2018.00312%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffnmol.2018.00312%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20Single%20Dose%20of%205-MeO-DMT%20Stimulates%20Cell%20Proliferation%2C%20Neuronal%20Survivability%2C%20Morphological%20and%20Functional%20Changes%20in%20Adult%20Mice%20Ventral%20Dentate%20Gyrus%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rafael%20Vitor%22%2C%22lastName%22%3A%22Lima%20da%20Cruz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thiago%20C.%22%2C%22lastName%22%3A%22Moulin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lyvia%20Lintzmaier%22%2C%22lastName%22%3A%22Petiz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richardson%20N.%22%2C%22lastName%22%3A%22Le%5Cu00e3o%22%7D%5D%2C%22abstractNote%22%3A%22%28Available%20in%20free%20full%20text%29%20The%20subgranular%20zone%20%28SGZ%29%20of%20dentate%20gyrus%20%28DG%29%20is%20one%20of%20the%20few%20regions%20in%20which%20neurogenesis%20is%20maintained%20throughout%20adulthood.%20It%20is%20believed%20that%20newborn%20neurons%20in%20this%20region%20encode%20temporal%20information%20about%20partially%20overlapping%20contextual%20memories.%20The%205-Methoxy-N%2CN-dimethyltryptamine%20%285-MeO-DMT%29%20is%20a%20naturally%20occurring%20compound%20capable%20of%20inducing%20a%20powerful%20psychedelic%20state.%20Recently%2C%20it%20has%20been%20suggested%20that%20DMT%20analogs%20may%20be%20used%20in%20the%20treatment%20of%20mood%20disorders.%20Due%20to%20the%20strong%20link%20between%20altered%20neurogenesis%20and%20mood%20disorders%2C%20we%20tested%20whether%205-MeO-DMT%20is%20capable%20of%20increasing%20DG%20cell%20proliferation.%20We%20show%20that%20a%20single%20intracerebroventricular%20%28ICV%29%20injection%20of%205-MeO-DMT%20increases%20the%20number%20of%20Bromodeoxyuridine%20%28BrdU%2B%29%20cells%20in%20adult%20mice%20DG.%20Moreover%2C%20using%20a%20transgenic%20animal%20expressing%20tamoxifen-dependent%20Cre%20recombinase%20under%20doublecortin%20promoter%2C%20we%20found%20that%205%20Meo-DMT%20treated%20mice%20had%20a%20higher%20number%20of%20newborn%20DG%20Granule%20cells%20%28GC%29.%20We%20also%20showed%20that%20these%20DG%20GC%20have%20more%20complex%20dendritic%20morphology%20after%205-MeO-DMT.%20Lastly%2C%20newborn%20GC%20treated%20with%205-MeO-DMT%2C%20display%20shorter%20afterhyperpolarization%20%28AHP%29%20potentials%20and%20higher%20action%20potential%20%28AP%29%20threshold%20compared.%20Our%20findings%20show%20that%205-MeO-DMT%20affects%20neurogenesis%20and%20this%20effect%20may%20contribute%20to%20the%20known%20antidepressant%20properties%20of%20DMT-derived%20compounds.%22%2C%22date%22%3A%222018-September-04%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.3389%5C%2Ffnmol.2018.00312%22%2C%22ISSN%22%3A%221662-5099%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.frontiersin.org%5C%2Farticle%5C%2F10.3389%5C%2Ffnmol.2018.00312%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22SPXM7K8T%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Uthaug%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BUthaug%2C%20M.%20V.%2C%20Lancelotta%2C%20R.%2C%20van%20Oorsouw%2C%20K.%2C%20Kuypers%2C%20K.%20P.%20C.%2C%20Mason%2C%20N.%2C%20Rak%2C%20J.%2C%20%26%23x160%3Bul%26%23xE1%3Bkov%26%23xE1%3B%2C%20A.%2C%20Jurok%2C%20R.%2C%20Mary%26%23x161%3Bka%2C%20M.%2C%20Kucha%26%23x159%3B%2C%20M.%2C%20P%26%23xE1%3Blen%26%23xED%3B%26%23x10D%3Bek%2C%20T.%2C%20Riba%2C%20J.%2C%20%26amp%3B%20Ramaekers%2C%20J.%20G.%20%282019%29.%20A%20single%20inhalation%20of%20vapor%20from%20dried%20toad%20secretion%20containing%205-methoxy-N%2CN-dimethyltryptamine%20%285-MeO-DMT%29%20in%20a%20naturalistic%20setting%20is%20related%20to%20sustained%20enhancement%20of%20satisfaction%20with%20life%2C%20mindfulness-related%20capacities%2C%20and%20a%20decrement%20of%20psychopathological%20symptoms.%20%26lt%3Bi%26gt%3BPsychopharmacology%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00213-019-05236-w%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00213-019-05236-w%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20single%20inhalation%20of%20vapor%20from%20dried%20toad%20secretion%20containing%205-methoxy-N%2CN-dimethyltryptamine%20%285-MeO-DMT%29%20in%20a%20naturalistic%20setting%20is%20related%20to%20sustained%20enhancement%20of%20satisfaction%20with%20life%2C%20mindfulness-related%20capacities%2C%20and%20a%20decrement%20of%20psychopathological%20symptoms%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20V.%22%2C%22lastName%22%3A%22Uthaug%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Lancelotta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22van%20Oorsouw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20P.%20C.%22%2C%22lastName%22%3A%22Kuypers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Mason%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Rak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22%5Cu0160ul%5Cu00e1kov%5Cu00e1%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Jurok%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Mary%5Cu0161ka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Kucha%5Cu0159%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%22%2C%22lastName%22%3A%22P%5Cu00e1len%5Cu00ed%5Cu010dek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Riba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20G.%22%2C%22lastName%22%3A%22Ramaekers%22%7D%5D%2C%22abstractNote%22%3A%22%28Available%20in%20free%20full%20text%29%20Background%205-methoxy-N%2CN-dimethyltryptamine%20%28hereinafter%20referred%20to%20as%205-MeO-DMT%29%20is%20a%20psychedelic%20substance%20found%20in%20the%20secretion%20from%20the%20parotoid%20glands%20of%20the%20Bufo%20alvarius%20toad.%20Inhalation%20of%20vapor%20from%20toad%20secretion%20containing%205-MeO-DMT%20has%20become%20popular%20in%20naturalistic%20settings%20as%20a%20treatment%20of%20mental%20health%20problems%20or%20as%20a%20means%20for%20spiritual%20exploration.%20However%2C%20knowledge%20of%20the%20effects%20of%205-MeO-DMT%20in%20humans%20is%20limited.%20%20Aims%20The%20first%20objective%20of%20this%20study%20was%20to%20assess%20sub-acute%20and%20long-term%20effects%20of%20inhaling%20vapor%20from%20dried%20toad%20secretion%20containing%205-MeO-DMT%20on%20affect%20and%20cognition.%20The%20second%20objective%20was%20to%20assess%20whether%20any%20changes%20were%20associated%20with%20the%20psychedelic%20experience.%20%20Methods%20Assessments%20at%20baseline%2C%20within%2024%20h%20and%204%20weeks%20following%20intake%2C%20were%20made%20in%2042%20individuals%20who%20inhaled%20vapor%20from%20dried%20toad%20secretion%20at%20several%20European%20locations.%20%20Results%20Relative%20to%20baseline%2C%20ratings%20of%20satisfaction%20with%20life%20and%20convergent%20thinking%20significantly%20increased%20right%20after%20intake%20and%20were%20maintained%20at%20follow-up%204%20weeks%20later.%20Ratings%20of%20mindfulness%20also%20increased%20over%20time%20and%20reached%20statistical%20significance%20at%204%20weeks.%20Ratings%20of%20depression%2C%20anxiety%2C%20and%20stress%20decreased%20after%20the%20session%2C%20and%20reached%20significance%20at%204%20weeks.%20Participants%20that%20experienced%20high%20levels%20of%20ego%20dissolution%20or%20oceanic%20boundlessness%20during%20the%20session%20displayed%20higher%20ratings%20of%20satisfaction%20with%20life%20and%20lower%20ratings%20of%20depression%20and%20stress.%20%20Conclusion%20A%20single%20inhalation%20of%20vapor%20from%20dried%20toad%20secretion%20containing%205-MeO-DMT%20produces%20sub-acute%20and%20long-term%20changes%20in%20affect%20and%20cognition%20in%20volunteers.%20These%20results%20warrant%20exploratory%20research%20into%20therapeutic%20applications%20of%205-MeO-DMT.%22%2C%22date%22%3A%222019%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00213-019-05236-w%22%2C%22ISSN%22%3A%221432-2072%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00213-019-05236-w%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%2C%7B%22key%22%3A%2249RTNJPS%22%2C%22library%22%3A%7B%22id%22%3A1176526%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sessa%20et%20al.%22%2C%22parsedDate%22%3A%222019-03%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSessa%2C%20B.%2C%20Higbed%2C%20L.%2C%20%26amp%3B%20Nutt%2C%20D.%20%282019%29.%20A%20review%20of%203%2C4-methylenedioxymethamphetamine%20%28MDMA%29-assisted%20psychotherapy.%20%26lt%3Bi%26gt%3BFrontiers%20in%20Psychiatry%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B10%26lt%3B%5C%2Fi%26gt%3B%28138%29.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffpsyt.2019.00138%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffpsyt.2019.00138%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20review%20of%203%2C4-methylenedioxymethamphetamine%20%28MDMA%29-assisted%20psychotherapy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ben%22%2C%22lastName%22%3A%22Sessa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurie%22%2C%22lastName%22%3A%22Higbed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Nutt%22%7D%5D%2C%22abstractNote%22%3A%22%28Available%20in%20free%20full%20text%29%20This%20paper%20provides%20a%20brief%20review%20of%20the%20history%2C%20proposed%20pharmacological%20mechanisms%2C%20safety%20issues%20and%20clinical%20applications%20of%20the%20medicine%203%2C4-methylenedioxymethamphetamine%20%28MDMA%29.%20Most%20clinical%20MDMA%20research%20in%20patients%20to%20date%20has%20focused%20on%20MDMA-assisted%20psychotherapy%20to%20treat%20posttraumatic%20stress%20disorder%20%28PTSD%29.%20In%20this%20review%20paper%20other%20potential%20therapeutic%20applications%20for%20MDMA%20therapy%20are%20described%2C%20including%20contemporary%20studies%20treating%20anxiety%20associated%20with%20autism%20and%20the%20authors%5Cu2019%20ongoing%20study%20exploring%20the%20potential%20role%20for%20MDMA-assisted%20psychotherapy%20to%20treat%20alcohol%20use%20disorder.%20MDMA%20therapy%20for%20PTSD%20is%20now%20entering%20the%20final%20Phase%203%20stage%20of%20drug%20development%2C%20with%20a%20target%20set%20for%20licensing%20by%20the%20FDA%20and%20EMA%20in%202021.%20This%20means%20that%20if%20clinical%20efficacy%20criteria%20are%20achieved%2C%20MDMA%20would%20become%20a%20medicine.%22%2C%22date%22%3A%222019-March-20%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.3389%5C%2Ffpsyt.2019.00138%22%2C%22ISSN%22%3A%221664-0640%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.frontiersin.org%5C%2Farticle%5C%2F10.3389%5C%2Ffpsyt.2019.00138%22%2C%22collections%22%3A%5B%22CNBFREKQ%22%5D%2C%22dateModified%22%3A%222024-01-14T16%3A56%3A03Z%22%7D%7D%5D%7D
Aaronson, S. T., van der Vaart, A., Miller, T., LaPratt, J., Swartz, K., Shoultz, A., Lauterbach, M., Sackeim, H. A., & Suppes, T. (2023). Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Controlled Trial. JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2023.4685
Barrett, F. S., Preller, K. H., & Kaelen, M. (2018). Psychedelics and music: neuroscience and therapeutic implications. International Review of Psychiatry, 30(4), 350–362. https://doi.org/10.1080/09540261.2018.1484342
Luan, L. X., Eckernäs, E., Ashton, M., Rosas, F. E., Uthaug, M. V., Bartha, A., Jagger, S., Gascon-Perai, K., Gomes, L., Nutt, D. J., Erritzøe, D., Carhart-Harris, R. L., & Timmermann, C. (2023). Psychological and physiological effects of extended DMT. Journal of Psychopharmacology, 02698811231196877. https://doi.org/10.1177/02698811231196877
Gründer, G., Brand, M., Mertens, L. J., Jungaberle, H., Kärtner, L., Scharf, D. J., Spangemacher, M., & Wolff, M. (2023). Treatment with psychedelics is psychotherapy: beyond reductionism. The Lancet Psychiatry, 0(0). https://doi.org/10.1016/S2215-0366(23)00363-2
The Transpersonal: Spirituality in Psychotherapy and Counselling. (n.d.). Routledge & CRC Press. Retrieved November 13, 2023, from https://www.routledge.com/The-Transpersonal-Spirituality-in-Psychotherapy-and-Counselling/Rowan/p/book/9781138881495
The Cosmic Game: Explorations of... by Grof, Stanislav. (n.d.). Retrieved November 13, 2023, from https://www.amazon.co.uk/Cosmic-Game-Explorations-Consciousness-Transpersonal/dp/0791438767/ref=sr_1_1?crid=10SSGELBX8O9Q&keywords=grof+cosmic&qid=1699840212&s=books&sprefix=grof+cosmic%2Cstripbooks%2C80&sr=1-1
Letheby, C. (2021). Philosophy of Psychedelics. Oxford University Press. https://philarchive.org/rec/LETPOP
The Transpersonal: Spirituality... by Rowan, John. (n.d.). Retrieved November 13, 2023, from https://www.amazon.co.uk/Transpersonal-John-Rowan/dp/1583919872/ref=sr_1_3?crid=17M4WK9OHWLWV&keywords=rowan+john&qid=1699840354&s=books&sprefix=rowan+john%2Cstripbooks%2C88&sr=1-3
The Transpersonal: Psychotherapy and... by Rowan, John. (n.d.). Retrieved November 13, 2023, from https://www.amazon.co.uk/Transpersonal-Psychotherapy-Counselling-John-Rowan/dp/0415053625
Otherworlds: Psychedelics and Exceptional Human Experience (Muswell Hill Press) : Luke, David: Amazon.co.uk: Books. (n.d.). Retrieved November 13, 2023, from https://www.amazon.co.uk/Otherworlds-Psychedelics-Exceptional-Experience-Muswell/dp/1908995149
Hoffman, D. D. (2020). The Case Against Reality: How Evolution Hid the Truth from Our Eyes (1st edition). Penguin.
Carhart-Harris, R. L., & Goodwin, G. M. (2017). The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Neuropsychopharmacology, 42(11), 2105–2113. https://doi.org/10.1038/npp.2017.84
Maclean, K. A., Leoutsakos, J.-M. S., Johnson, M. W., & Griffiths, R. R. (2012). Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin. Journal for the Scientific Study of Religion, 51(4), 721–737. https://doi.org/10.1111/j.1468-5906.2012.01685.x
Self unbound: ego dissolution in psychedelic experience | Neuroscience of Consciousness | Oxford Academic. (n.d.). Retrieved October 6, 2022, from https://academic.oup.com/nc/article/2017/1/nix016/3916730
Survey of entity encounter experiences occasioned by inhaled N,N-dimethyltryptamine: Phenomenology, interpretation, and enduring effects - Alan K Davis, John M Clifton, Eric G Weaver, Ethan S Hurwitz, Matthew W Johnson, Roland R Griffiths, 2020. (n.d.). Retrieved November 11, 2023, from https://journals.sagepub.com/doi/full/10.1177/0269881120916143
Huxley, A. (2004). The doors of perception and Heaven and hell (1st Perennial Classics ed). Perennial Classics.
Aday, J. S., Bloesch, E. K., & Davoli, C. C. (2019). Beyond LSD: A Broader Psychedelic Zeitgeist during the Early to Mid-20th Century. Journal of Psychoactive Drugs, 51(3), 210–217. https://doi.org/10.1080/02791072.2019.1581961
Holze, F., Ley, L., Müller, F., Becker, A. M., Straumann, I., Vizeli, P., Kuehne, S. S., Roder, M. A., Duthaler, U., Kolaczynska, K. E., Varghese, N., Eckert, A., & Liechti, M. E. (2022). Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects. Neuropsychopharmacology, 47(6), 1180–1187. https://doi.org/10.1038/s41386-022-01297-2
Halberstadt, A. L., & Geyer, M. A. (2011). Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Neuropharmacology, 61(3), 364–381. https://doi.org/10.1016/j.neuropharm.2011.01.017
Carboué, Q., & Lopez, M. (2021). Amanita muscaria: Ecology, chemistry, myths. Encyclopedia, 1(3), 905–914. https://www.mdpi.com/2673-8392/1/3/69
Hastings, A. (2006). An Extended Nondrug MDMA-Like Experience Evoked Through Posthypnotic Suggestion. Journal of Psychoactive Drugs, 38(3), 273–283. https://doi.org/10.1080/02791072.2006.10399853
Castro Santos, H., & Gama Marques, J. (2021). What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review. Porto Biomedical Journal, 6(1), e128. https://doi.org/10.1097/j.pbj.0000000000000128
Reavey, P., Boden, Z., & Anderson, K. (2018). An Affective (Re)balancing Act? The Liminal Possibilities for Heterosexual Partners on MDMA. https://www.researchgate.net/publication/322791658_An_Affective_Rebalancing_Act_The_Liminal_Possibilities_for_Heterosexual_Partners_on_MDMA
Bonson, K. R., & Murphy, D. L. (1995). Alterations in responses to LSD in humans associated with chronic administration of tricyclic antidepressants, monoamine oxidase inhibitors or lithium. Behavioural Brain Research, 73(1), 229–233. https://doi.org/10.1016/0166-4328(96)00102-7
Parry, G. J., & Buenz, E. J. (2018). Adventures in self experimentation. Br Med J, 363, k5006. https://doi.org/10.1136/bmj.k5006
Papaseit, E., Farré, M., Pérez-Mañá, C., Torrens, M., Ventura, M., Pujadas, M., de la Torre, R., & González, D. (2018). Acute Pharmacological Effects of 2C-B in Humans: An Observational Study. Frontiers in Pharmacology, 9(206). https://doi.org/10.3389/fphar.2018.00206
Borissova, A., Ferguson, B., Wall, M. B., Morgan, C. J., Carhart-Harris, R. L., Bolstridge, M., Bloomfield, M. A., Williams, T. M., Feilding, A., Murphy, K., Tyacke, R. J., Erritzoe, D., Stewart, L., Wolff, K., Nutt, D., Curran, H. V., & Lawn, W. (2020). Acute effects of MDMA on trust, cooperative behaviour and empathy: A double-blind, placebo-controlled experiment. Journal of Psychopharmacology, 0(0), 0269881120926673. https://doi.org/10.1177/0269881120926673
Bouso, J. C., Fabregas, J. M., Antonijoan, R. M., Rodriguez-Fornells, A., & Riba, J. (2013). Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users. Psychopharmacology (Berl), 230(3), 415–424. https://doi.org/10.1007/s00213-013-3167-9
Zheng, W., Cai, D.-B., Xiang, Y.-Q., Zheng, W., Jiang, W.-L., Sim, K., Ungvari, G. S., Huang, X., Huang, X.-X., Ning, Y.-P., & Xiang, Y.-T. (2020). Adjunctive intranasal esketamine for major depressive disorder: A systematic review of randomized double-blind controlled-placebo studies. Journal of Affective Disorders, 265, 63–70. https://doi.org/10.1016/j.jad.2020.01.002
Michael, P., Luke, D., & Robinson, O. (2021). An Encounter with the Other: A Thematic Analysis of Accounts of DMT Experiences from a Naturalistic Field Study. PsyArXiv. https://doi.org/10.31234/osf.io/8cdgs
Davenport, L. (2021). Adjunctive MDMA safe, effective for severe PTSD. https://www.medscape.com/viewarticle/949243?src=WNL_mdpls_210416_mscpedit_psych&uac=25072MJ&spon=12&impID=3315763&faf=1
Kamboj, S. K., Walldén, Y. S. E., Falconer, C. J., Alotaibi, M. R., Blagbrough, I. S., Husbands, S. M., & Freeman, T. P. (2018). Additive effects of 3,4-Methylenedioxymethamphetamine (MDMA) and compassionate imagery on self-compassion in recreational users of ecstasy. Mindfulness, 9(4), 1134–1145. https://doi.org/10.1007/s12671-017-0849-0
Austin, E., Myron, H. S., Summerbell, R. K., & Mackenzie, C. A. (2019). Acute renal injury cause by confirmed Psilocybe cubensis mushroom ingestion. Medical Mycology Case Reports, 23, 55–57. https://doi.org/10.1016/j.mmcr.2018.12.007
Harwick, R. M., Carlini, B. H., & Garrett, S. B. (2020). A Taxonomy of Consumers’ Perspectives on the Function of Cannabis in Their Lives: A Qualitative Study in WA State, USA. Journal of Psychoactive Drugs, 1–8. https://doi.org/10.1080/02791072.2020.1763522
Ballew, M., & Omoto, A. (2018). Absorption: how nature experiences promote awe and other positive emotions. Ecopsychology, 10(1), 26–35. https://doi.org/10.1089/eco.2017.0044
Studerus, E., Kometer, M., Hasler, F., & Vollenweider, F. X. (2011). Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies. J Psychopharmacol, 25(11), 1434–1452. https://doi.org/10.1177/0269881110382466
Hasler, F., Grimberg, U., Benz, M. A., Huber, T., & Vollenweider, F. X. (2004). Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose–effect study. Psychopharmacology, 172(2), 145–156. https://doi.org/10.1007/s00213-003-1640-6
Holze, F., Vizeli, P., Ley, L., Müller, F., Dolder, P., Stocker, M., Duthaler, U., Varghese, N., Eckert, A., Borgwardt, S., & Liechti, M. E. (2020). Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects. Neuropsychopharmacology. https://doi.org/10.1038/s41386-020-00883-6
Kim, S., Rush, B. S., & Rice, T. R. (2020). A systematic review of therapeutic ketamine use in children and adolescents with treatment-resistant mood disorders. European Child & Adolescent Psychiatry. https://doi.org/10.1007/s00787-020-01542-3
Lifshitz, M., van Elk, M., & Luhrmann, T. M. (2019). Absorption and spiritual experience: A review of evidence and potential mechanisms. Consciousness and Cognition, 73, 102760. PubMed. https://doi.org/10.1016/j.concog.2019.05.008
Baggott, M. J., Coyle, J. R., Erowid, E., Erowid, F., & Robertson, L. C. (2011). Abnormal visual experiences in individuals with histories of hallucinogen use: a Web-based questionnaire. Drug Alcohol Depend, 114(1), 61–67. https://doi.org/10.1016/j.drugalcdep.2010.09.006
Madsen, M. K., Fisher, P. M., Stenbæk, D. S., Kristiansen, S., Burmester, D., Lehel, S., Páleníček, T., Kuchař, M., Svarer, C., Ozenne, B., & Knudsen, G. M. (2020). A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding. European Neuropsychopharmacology, 33, 71–80. https://doi.org/10.1016/j.euroneuro.2020.02.001
Rodrı́guez, P., Urbanavicius, J., Prieto, J. P., Fabius, S., Reyes, A. L., Havel, V., Sames, D., Scorza, C., & Carrera, I. (2020). A Single Administration of the Atypical Psychedelic Ibogaine or Its Metabolite Noribogaine Induces an Antidepressant-Like Effect in Rats. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.0c00152
Pribish, A., Wood, N., & Kalava, A. (2020). A review of nonanesthetic uses of ketamine. Anesthesiology Research and Practice, 2020, 5798285. https://doi.org/10.1155/2020/5798285
Halpern, J. H., Lerner, A. G., & Passie, T. (2018). A Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD. Curr Top Behav Neurosci, 36, 333–360. https://doi.org/10.1007/7854_2016_457
Dakwar, E., Nunes, E. V., Hart, C. L., Hu, M. C., Foltin, R. W., & Levin, F. R. (2018). A sub-set of psychoactive effects may be critical to the behavioral impact of ketamine on cocaine use disorder: Results from a randomized, controlled laboratory study. Neuropharmacology, 142, 270–276. https://doi.org/10.1016/j.neuropharm.2018.01.005
Dakwar, E., Levin, F., Hart, C. L., & al., et. (2020). A single ketamine infusion combined with motivational enhancement therapy for alcohol use disorder: A randomized midazolam-controlled pilot trial. American Journal of Psychiatry, 177(2), 125–133. https://doi.org/10.1176/appi.ajp.2019.19070684
Lima da Cruz, R. V., Moulin, T. C., Petiz, L. L., & Leão, R. N. (2018). A Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus. Frontiers in Molecular Neuroscience, 11(312). https://doi.org/10.3389/fnmol.2018.00312
Uthaug, M. V., Lancelotta, R., van Oorsouw, K., Kuypers, K. P. C., Mason, N., Rak, J., Šuláková, A., Jurok, R., Maryška, M., Kuchař, M., Páleníček, T., Riba, J., & Ramaekers, J. G. (2019). A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms. Psychopharmacology. https://doi.org/10.1007/s00213-019-05236-w
Sessa, B., Higbed, L., & Nutt, D. (2019). A review of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy. Frontiers in Psychiatry, 10(138). https://doi.org/10.3389/fpsyt.2019.00138